Document:

EX-4.6

 Exhibit 4.6 
  

 
  

BATH COUNTY ENERGY, LLC 

$300,000,000 
 Senior Secured
Notes due 2033 
 Additional Senior Secured Notes 

NOTE PURCHASE AGREEMENT 

 
  

DATED DECEMBER 11, 2017 
  

 
  

 TABLE OF CONTENTS 
  

							
		 		  	 	Page	 
		
	ARTICLE 1 AUTHORIZATION OF NOTES	  	 	2	 
			
	 Section 1.1
	 	Authorization of Notes	  	 	2	 
			
	 Section 1.2
	 	Supplemental Notes	  	 	2	 
			
	 Section 1.3
	 	Definitions and Principles of Interpretation	  	 	3	 
		
	 ARTICLE 2 SALE AND PURCHASE OF NOTES
	  	 	3	 
			
	 Section 2.1
	 	Initial Notes	  	 	3	 
		
	 ARTICLE 3 CLOSING
	  	 	4	 
			
	 Section 3.1
	 	Initial Closing	  	 	4	 
			
	 Section 3.2
	 	Tax Forms and Withholding	  	 	4	 
		
	 ARTICLE 4 CONDITIONS TO CLOSING
	  	 	5	 
			
	 Section 4.1
	 	Conditions Precedent to Signing	  	 	5	 
			
	 Section 4.2
	 	Conditions Precedent to Funding Date	  	 	5	 
		
	 ARTICLE 5 REPRESENTATIONS AND WARRANTIES OF THE BORROWER
	  	 	6	 
			
	 Section 5.1
	 	Representations and Warranties made on the NPA Closing Date	  	 	6	 
			
	 Section 5.2
	 	Representations and Warranties made on the Funding Date	  	 	6	 
		
	 ARTICLE 6 REPRESENTATIONS OF THE PURCHASERS
	  	 	7	 
			
	 Section 6.1
	 	Purchase for Investment; Status as an Accredited Investor; Investor Knowledge and Sophistication	  	 	7	 
			
	 Section 6.2
	 	Source of Funds	  	 	7	 
			
	 Section 6.3
	 	Notes Documents	  	 	9	 
		
	 ARTICLE 7 PAYMENT OF THE NOTES
	  	 	9	 
			
	 Section 7.1
	 	Payment; Maturity	  	 	9	 
			
	 Section 7.2
	 	Optional Prepayments with Make-Whole Amount	  	 	9	 
			
	 Section 7.3
	 	Allocation of Partial Prepayments	  	 	10	 
			
	 Section 7.4
	 	Maturity; Surrender, Etc.	  	 	10	 
			
	 Section 7.5
	 	Mandatory Offers to Prepay	  	 	10	 
			
	 Section 7.6
	 	Purchase of Notes	  	 	10	 
			
	 Section 7.7
	 	Make-Whole Amount	  	 	11	 
			
	 Section 7.8
	 	Payments Due on Non-Business Days	  	 	12	 
		
	 ARTICLE 8 AFFIRMATIVE COVENANTS
	  	 	13	 
			
	 Section 8.1
	 	Affirmative Covenants of the Borrower	  	 	13	 
			
	 Section 8.2
	 	Ratings	  	 	13	 

  
 i 

 TABLE OF CONTENTS 

(continued) 
  

							
		 		  	 	Page	 
		
	ARTICLE 9 NEGATIVE COVENANTS	  	 	13	 
			
	 Section 9.1
	 	Negative Covenants of the Borrower	  	 	13	 
		
	ARTICLE 10 EVENTS OF DEFAULT	  	 	13	 
		
	ARTICLE 11 RESCISSION	  	 	13	 
			
	 Section 11.1
	 	Rescission	  	 	13	 
		
	ARTICLE 12 REGISTRATION; EXCHANGE; SUBSTITUTION OF NOTES	  	 	14	 
			
	 Section 12.1
	 	Registration of Notes	  	 	14	 
			
	 Section 12.2
	 	Transfer and Exchange of Notes	  	 	14	 
			
	 Section 12.3
	 	Replacement of Notes	  	 	14	 
		
	ARTICLE 13 PAYMENT ON NOTES	  	 	15	 
			
	 Section 13.1
	 	Place of Payment	  	 	15	 
			
	 Section 13.2
	 	Home Office Payment	  	 	15	 
		
	 ARTICLE 14 EXPENSES, ETC.
	  	 	16	 
			
	 Section 14.1
	 	Transaction Expenses	  	 	16	 
			
	 Section 14.2
	 	Survival	  	 	16	 
		
	ARTICLE 15 SURVIVAL OF REPRESENTATIONS AND WARRANTIES; ENTIRE AGREEMENT	  	 	16	 
		
	ARTICLE 16 AMENDMENTS AND WAIVERS	  	 	16	 
			
	 Section 16.1
	 	Requirements	  	 	16	 
			
	 Section 16.2
	 	Solicitation of Holders of Notes	  	 	17	 
			
	 Section 16.3
	 	Binding Effect, Etc.	  	 	17	 
			
	 Section 16.4
	 	Notes Held by the Obligors, Etc.	  	 	18	 
		
	ARTICLE 17 NOTICES	  	 	18	 
		
	ARTICLE 18 REPRODUCTION OF DOCUMENTS	  	 	18	 
		
	ARTICLE 19 CONFIDENTIAL INFORMATION	  	 	18	 
		
	ARTICLE 20 SUBSTITUTION OF PURCHASER	  	 	19	 
		
	ARTICLE 21 MISCELLANEOUS	  	 	19	 
			
	 Section 21.1
	 	Successors and Assigns	  	 	19	 
			
	 Section 21.2
	 	Severability	  	 	20	 
			
	 Section 21.3
	 	Construction, Etc.	  	 	20	 
			
	 Section 21.4
	 	Counterparts	  	 	20	 
			
	 Section 21.5
	 	Governing Law	  	 	20	 

  
 ii 

 TABLE OF CONTENTS 

(continued) 
  

							
		 		  	 	Page	 
			
	 Section 21.6
	 	Jurisdiction and Process; Waiver of Jury Trial	  	 	20	 
			
	 Section 21.7
	 	Counsel	  	 	20	 

  
 iii 

			
	 SCHEDULES
	  	
		
	 Schedule A
	  	 Defined Terms

	 Schedule B
	  	 Information Relating To Purchasers

	 Schedule 1
	  	 Form of Initial Notes

	 Schedule 2
	  	 Form of Additional Senior Notes

	 Schedule 3
	  	 Form of Supplement

	 Schedule 5.2
	  	 Disclosure Materials

  
 iv 

 Senior Secured Notes due 2033 

Additional Senior Notes 

December 11, 2017 
 TO
EACH OF THE PURCHASERS LISTED IN 
 Schedule B
Hereto: 
 Ladies and Gentlemen: 
 Bath County
Energy, LLC, a Delaware limited liability company (the “Borrower”), agrees with each of the purchasers under the caption “INITIAL PURCHASERS” on the signature pages hereof (each an “Initial Purchaser” and,
collectively, the “Initial Purchasers”) and each purchaser that executes and delivers a Supplement as provided in Section 1.2 (each, together with each Initial Purchaser, a “Purchaser” and,
collectively with the Initial Purchasers, the “Purchasers”) as follows: 
 W I T N E S S E T H: 

WHEREAS, the Borrower is a wholly-owned indirect subsidiary, and Bath County Energy Holdings, LLC (“Holdings”) is a
wholly-owned direct subsidiary, of Aspen Generating, LLC, a Delaware limited liability company (the “Acquisition Parent Company”); 

WHEREAS, pursuant to that certain Amended and Restated Equity Interest and Asset Purchase Agreement, dated as of August 30, 2017
(the “Purchase Agreement”), among Allegheny Energy Supply Company, LLC, a Delaware limited liability company (“AE Supply”), Buchanan Energy Company of Virginia, LLC, a Virginia LLC, Allegheny Generating Company, a
Virginia corporation (“Allegheny” and, together with AE Supply, each a “Seller” and, collectively, the “Sellers”) and the Acquisition Parent Company, the Acquisition Parent Company has agreed to,
among other things, purchase the Purchased Bath Assets (as defined in the Purchase Agreement) (the “Acquisition”); 

WHEREAS, pursuant to that certain Assignment Agreement to be dated as of the date of the closing of the Acquisition between the
Acquisition Parent Company and the Borrower (the “Assignment Agreement”), the Acquisition Parent Company will assign to the Borrower its right to acquire the Project from Allegheny; 

WHEREAS, the Borrower is entering into the Credit Agreement, dated as of the date hereof (as amended, amended and restated,
supplemented, refinanced, replaced or otherwise modified from time to time, the “Credit Agreement”), with the Administrative Agent, each of the Lenders party thereto from time to time and each of the Revolving Facility Issuing Banks
party thereto from time to time, which, among other things, establishes certain senior secured credit facilities, pursuant to which the Lender Parties will agree, inter alia, to provide Revolving Loans and Letters of Credit under a Revolving
Facility to fund working capital expenditures and for other general corporate purposes, including to support the obligations of the Borrower under Permitted Commodity Hedge and Power Sales Agreements, the Bath Operating Agreement, and other
collateral requirements of the Borrower, and to fund the Debt Service Reserve Account, and the Lenders and the Revolving Facility Issuing Banks are willing to provide such senior secured credit facilities; 

  
 - 1 - 

 WHEREAS, in order to finance a portion of the purchase price of the Acquisition and
to fund certain transaction costs, fees and expenses incurred or payable by the Borrower in connection with the financings described herein, the Borrower has requested the Purchasers to purchase the Notes in the aggregate principal amount of up to
$300,000,000 to be issued by the Borrower pursuant to the terms and conditions set forth in this Agreement and in the Common Terms Agreement referred to below; 

WHEREAS, the Borrower, the Administrative Agent, the Collateral Agent, the Intercreditor Agent, and the Purchasers, Lenders, and
Revolving Facility Issuing Banks from time to time parties thereto have entered into the Common Terms Agreement, dated as of the date hereof (the “Common Terms Agreement”), which contains certain representations, covenants and
events of default for the common benefit of the Financing Parties; and 
 NOW, THEREFORE, in consideration of the premises and mutual
agreements hereinafter contained, the parties hereto agree as follows: 
 ARTICLE 1 

AUTHORIZATION OF NOTES 

Section 1.1 Authorization of Notes. The Borrower will authorize the issue and sale of $300,000,000 aggregate principal amount of
its 4.58% (as adjusted pursuant to footnote 1 of Schedule 1) Senior Secured Notes due on the fifteenth anniversary of the Funding Date (as amended, restated or otherwise modified from time to time pursuant to
Article 16 and including any such notes issued in substitution therefor pursuant to Article 12, the “Initial Notes”). The Initial Notes shall be substantially in the form set out
in Schedule 1. In addition, the Borrower may issue and sell, subject to the terms and conditions of this Agreement, an unlimited aggregate principal amount of additional senior notes based on the form of Schedule 2
as provided in Section 1.2 (as amended, restated or otherwise modified from time to time pursuant to Article 16 and including any such notes issued in substitution therefor pursuant to Article 12, the
“Additional Senior Notes,” and together with the Initial Notes, the “Notes”). The Additional Senior Notes may be issued in one or more series (the Initial Notes and each such series, a “Series” of
Notes), subject to compliance with the terms and conditions of this Agreement. 
 Section 1.2 Supplemental Notes. Each
Additional Senior Note will be issued pursuant to a supplement to this Agreement (a “Supplement”) based on the form of Schedule 3, and will be subject to the following terms and conditions: 

(a) the designation of each Series of Notes shall distinguish the Notes of one Series from the Notes of all other Series; 

(b) the Notes of each Series of Additional Senior Notes shall rank pari passu in right of payment with the Notes of each other Series
of Notes; 

  
 - 2 - 

 (c) the issuance of the Additional Senior Notes shall constitute Permitted Refinancing
Indebtedness to refinance all or any portion of Indebtedness permitted under Section 8.5 of the Common Terms Agreement; 
 (d) each
Additional Senior Note shall be dated the date of issue, shall bear interest at such rate or rates, shall mature on such date or dates, if any, as are provided in the Supplement under which such Additional Senior Notes are issued, may be issued in
such denominations, may be subject to payment of such Make-Whole Amount or premium or without premium, may contain tax indemnification provisions, and provisions for the exchange or transfer of such Additional Senior Notes and may have such
additional or different conditions precedent to closing and such additional or different representations and warranties or other terms and provisions as shall be specified in such Supplement; 

(e) except to the extent provided in clause (d) above or as otherwise specified in this Agreement, all of the
provisions of this Agreement shall apply to the Notes, including the Additional Senior Notes; and 
 (f) no Additional Senior Note shall be
issued to a Purchaser that is an Affiliate of the Borrower. 
 The Purchasers of the Initial Notes or any Additional Senior Notes are under
no obligation to purchase any subsequent Additional Senior Notes. 
 Upon the issuance of any Additional Senior Notes, the Borrower shall,
at its expense, provide, or cause to be provided, to each Holder the Supplement entered into in connection with such Notes. 

Section 1.3 Definitions and Principles of Interpretation. Certain capitalized and other terms used in this Agreement are
defined in Schedule A to this Agreement. Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed thereto in the Common Terms Agreement. The rules of interpretation set forth in Section 1.2 of
the Common Terms Agreement shall also apply in this Agreement as if set forth herein mutatis mutandis. 
 ARTICLE 2 

SALE AND PURCHASE OF NOTES 

Section 2.1 Initial Notes. Subject to the terms and conditions of this Agreement, the Borrower will issue and sell to each
Initial Purchaser and each Initial Purchaser will purchase from the Borrower, at the NPA Funding Date provided for in Section 3.1, the Initial Notes in the principal amount specified opposite such Initial Purchaser’s
name in Schedule B at the purchase price of 100% of the principal amount thereof. The Purchasers’ obligations hereunder are several and not joint obligations, and no Purchaser shall have any liability to any
Person for the performance or non-performance of any obligation by any other Purchaser hereunder. 

  
 - 3 - 

 ARTICLE 3 

CLOSING 
 Section 3.1
Initial Closing. The sale and purchase of the Initial Notes to be purchased by each Purchaser shall occur at the offices of Shearman & Sterling LLP, 599 Lexington Avenue, New York, New York, at 9:00 a.m., Eastern time, at a closing
(the “NPA Funding Date”) on such day as is designated by the Borrower at least three (3) Business Days prior thereto, which day shall be on or prior to October 1, 2018. At the NPA Funding Date, the Borrower will deliver to
each Initial Purchaser the Initial Notes to be purchased by such Initial Purchaser in the form of a single Initial Note (or such greater number of Initial Notes in denominations of at least $100,000 as such Purchaser may request) dated the date of
the NPA Funding Date and registered in such Initial Purchaser’s name (or in the name of its nominee), against delivery by such Initial Purchaser to the Borrower or its order of immediately available funds in the amount of the purchase price
therefor by wire transfer of immediately available funds to the account specified in the Funds Flow Memorandum, for distribution, notwithstanding anything to the contrary in the Intercreditor Agreement or any other Financing Document (as defined in
the Intercreditor Agreement), in accordance with the Funds Flow Memorandum. If at the NPA Funding Date, the Borrower shall fail to tender such Initial Notes to any Initial Purchaser as provided above in this Section 3.1, or
any of the conditions specified in Article 4 shall not have been fulfilled to such Initial Purchaser’s satisfaction, such Initial Purchaser shall, at its election, be relieved of all further obligations under this
Agreement and each other Credit Document, without thereby waiving any rights such Initial Purchaser may have by reason of any of the conditions specified in Article 4 not having been fulfilled to such Purchaser’s
satisfaction or such failure by the Borrower to tender such Initial Notes. 
 Section 3.2 Tax Forms and
Withholding. At or prior to the time that it purchases a Note (including by succession or pursuant to an assignment permitted hereunder) and, so long as it remains legally eligible to do so, from time to time thereafter, each Purchaser will duly
complete and deliver to the Borrower (a) in the case of a Purchaser that is not a United States person for U.S. federal income Tax purposes, two copies of any U.S. Internal Revenue Service (“IRS”) Forms W-8 or W-8BEN E as applicable (or other category of Form W-8 prescribed by law and acceptable to the Borrower in its discretion) along
with any supporting statements or additional information, in each case, that are reasonably necessary to establish the extent to which the Purchaser is entitled to a reduction in the rate of any U.S. withholding Tax imposed with respect to
payments on the Notes and any successor or additional form required by the IRS or reasonably requested by the Borrower in order to evidence such Purchaser’s entitlement to such reduction or (b) in the case of a Purchaser that is a United
States person for U.S. federal income Tax purposes, an IRS Form W-9 or successor form establishing that the Purchaser is not subject to any U.S. withholding Tax (including backup withholding
Tax) with respect to payments on the Notes and any other forms or information reasonably requested by the Borrower necessary for the Borrower to comply with its obligations under FATCA and to determine that such Purchaser has complied with its
obligations under FATCA or to determine the amount (if any) to deduct and withhold from any payment to the Purchaser. For the avoidance of doubt, if the Borrower (or any applicable withholding agent) is required by applicable law to deduct or
withhold any Taxes (including under FATCA) from or with respect to a Note or payments under a Note, then (a) the Borrower (or applicable withholding agent) may make such withholding or deduction and remit such Taxes to the applicable
Governmental Authority, (b) the Borrower shall not be obligated to indemnify the holder or beneficial owner of such Note or pay any additional amounts with respect to such withholding or deduction and (c) such withheld amounts shall be
treated as paid with respect to such Note for all purposes of this Agreement. 

  
 - 4 - 

 ARTICLE 4 

CONDITIONS TO CLOSING 

Section 4.1 Conditions Precedent to Signing. Each Initial Purchaser’s obligation to sign this Agreement is subject to the
fulfillment to such Initial Purchaser’s satisfaction, prior to or at such signing, of each of the conditions precedent set forth in Section 5.1 of the Common Terms Agreement and the following condition (or waiver thereof by each Initial
Purchaser): 
 (a) Ratings. Such Initial Purchaser shall have received evidence reasonably satisfactory to it that the Initial
Notes will be rated at least BBB or equivalent from KBRA. 
 Section 4.2 Conditions Precedent to Funding Date. Each Initial
Purchaser’s obligation to purchase and pay for the Initial Notes to be sold to such Initial Purchaser at the NPA Funding Date is subject to the fulfillment to such Initial Purchaser’s satisfaction, prior to or at the NPA Funding Date, of
each of the conditions precedent set forth in Section 5.2 of the Common Terms Agreement and of the following conditions (or waiver thereof by each Initial Purchaser): 

(a) Performance; No Default. The Borrower shall have performed and complied with all agreements and conditions contained in this
Agreement required to be performed or complied with by it prior to or at the time of the NPA Funding Date. The Borrower shall not have entered into any transaction since the date of the Memorandum that would have been prohibited by Article 9
had such Article applied since such date. 
 (b) Purchase Permitted by Applicable Law, Etc. On the Funding Date
such Initial Purchaser’s purchase of Initial Notes shall (a) be permitted by the laws and regulations of each jurisdiction to which such Initial Purchaser is subject, without recourse to provisions (such as section 1405(a)(8) of the
New York Insurance Law) permitting limited investments by insurance companies without restriction as to the character of the particular investment, (b) not violate any applicable law or regulation (including, without limitation,
Regulation T, U or X of the Board of Governors of the Federal Reserve System) and (c) not subject such Initial Purchaser to any Tax for which an indemnity is not available hereunder, penalty or liability under or pursuant to any applicable
law or regulation, which applicable law or regulation was not in effect on the date hereof. If requested by such Initial Purchaser at least three (3) Business Days prior to the Funding Date, such Initial Purchaser shall have received an
Officer’s Certificate certifying as to such matters of fact relating to the Borrower as such Initial Purchaser may reasonably specify to enable such Initial Purchaser to determine whether such purchase is so permitted. 

(c) Sale of Other Initial Notes. Contemporaneously with the Funding Date, the Borrower shall sell to each other Initial Purchaser and
each other Initial Purchaser shall purchase the Initial Notes to be purchased by it at the NPA Funding Date as specified in Schedule B. 

  
 - 5 - 

 (d) Private Placement Number. A Private Placement Number issued by
Standard & Poor’s CUSIP Service Bureau (in cooperation with the SVO) shall have been obtained for the Initial Notes. 
 (e)
Changes in Corporate Structure. The Borrower shall not have changed its jurisdiction of organization, or been a party to any merger or consolidation or succeeded to all or any substantial part of the liabilities of any other entity, at any
time, following the date of the most recent financial statements referred to in Sections 5.1(c) and 5.1(f) of the Common Terms Agreement. 

(f) Funding Instructions. At least three (3) Business Days prior to the date of the NPA Funding Date, each Initial Purchaser shall
have received written instructions signed by a Responsible Officer on letterhead of the Borrower confirming the information specified in Article 3 including (a) the name and address of the transferee bank,
(b) such transferee bank’s ABA number and (c) the account name and number into which the purchase price for the Initial Notes is to be deposited. 

(g) Notes. Each Purchaser shall have received its respective Note(s) as required pursuant to Section 3.1
above. 
 ARTICLE 5 

REPRESENTATIONS AND WARRANTIES OF THE BORROWER 

The Borrower represents and warrants to each Initial Purchaser as follows: 

Section 5.1 Representations and Warranties made on the NPA Closing Date. The Borrower confirms the representations and warranties
set forth in Section 4 of the Common Terms Agreement (other than Section 4.1, Section 4.6 and Section 4.9(b) and (c)) are hereby incorporated by reference as if fully set forth in this Agreement and are made by the Borrower as of
the date of the date hereof. 
 Section 5.2 Representations and Warranties made on the Funding Date. The Borrower confirms the
representations and warranties set forth in Section 4 of the Common Terms Agreement are hereby incorporated by reference as if fully set forth in this Agreement and are made by the Borrower as of the Funding Date. The Borrower further
represents and warrants that: 
 (a) Disclosure. The Borrower has delivered to each Purchaser a copy of a Private Placement
Memorandum, dated November 10, 2017 (the “Memorandum”), relating to the transactions contemplated hereby. This Agreement, the Memorandum, the financial statements furnished to the Purchasers pursuant to Section 5.1(c) of
the Common Terms Agreement and the documents, certificates or other writings delivered to the Purchasers by or on behalf of the Borrower prior to the Funding Date in connection with the transactions contemplated hereby and identified in
Schedule 5.2 (this Agreement, the Memorandum and such documents, certificates or 

  
 - 6 - 

 
other writings and such financial statements delivered to each Purchaser being referred to, collectively, as the “Disclosure Documents”), taken as a whole, do not contain any
untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading in light of the circumstances under which they were made; provided that the Base Case Model (which has been
prepared using assumptions believed by the Borrower in good faith to be reasonable at the time made, with no assurances as to actual outcome which may deviate materially from such forecast and projections) projections, forecasts or other
forward-looking information or information of a general industry nature shall not be considered Disclosure Documents. 
 (b) Private
Offering by the Borrower. Neither the Borrower nor anyone acting on the Borrower’s behalf has offered the Initial Notes or any similar Securities for sale to, or solicited any offer to buy the Notes or any similar Securities from, or
otherwise approached or negotiated in respect thereof with, any Person other than the Purchasers and not more than 50 other Institutional Investors, each of which has been offered the Initial Notes at a private sale for investment. Neither the
Borrower nor anyone acting on the Borrower’s behalf has taken, or will take, any action that would subject the issuance or sale of the Initial Notes to the registration requirements of section 5 of the Securities Act or to the registration
requirements of any securities or blue sky laws of any applicable jurisdiction. 
 ARTICLE 6 

REPRESENTATIONS OF THE PURCHASERS 

Section 6.1 Purchase for Investment; Status as an Accredited Investor; Investor Knowledge and Sophistication. Each
Initial Purchaser severally represents that (a) it is purchasing the Initial Notes for its own account or for one or more separate accounts maintained by such Initial Purchaser or for the account of one or more pension or trust funds and not
with a view to the distribution thereof; provided that the disposition of such Initial Purchaser’s or their property shall at all times be within such Initial Purchaser’s or their control, (b) it is an “accredited
investor” (as defined in Rule 501(a)(1), (2), (3), (7) or (8) under the Securities Act), (c) it has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an
investment in the Initial Notes, (d) it and any accounts for which it is acting are each able to bear the economic risk of its investments and (e) it has received adequate information concerning the Borrower and the Initial Notes to make
an informed investment decision with respect to the purchase of the Initial Notes. Each Initial Purchaser understands that the Initial Notes have not been, and will not be, registered under the Securities Act (and that the Borrower is not required
to register the Initial Notes) and may be resold only (x) if registered pursuant to the provisions of the Securities Act, (y) if an exemption from registration is available or (z) if resold under circumstances where neither such
registration nor such exemption is required by law, and that the Borrower is not required to register the Initial Notes. 

Section 6.2 Source of Funds. Each Initial Purchaser severally represents that at least one of the following statements is
an accurate representation as to each source of funds (a “Source”) to be used by such Initial Purchaser to pay the purchase price of the Initial Notes to be purchased by such Initial Purchaser hereunder: 

  
 - 7 - 

 (a) the Source is an “insurance company general account” (as the term is defined
in the United States Department of Labor’s Prohibited Transaction Exemption (“PTE”) 95-60) in respect of which the reserves and liabilities (as defined by the annual statement for life
insurance companies approved by the NAIC (the “NAIC Annual Statement”)) for the general account contract(s) held by or on behalf of any employee benefit plan together with the amount of the reserves and liabilities for the general
account contract(s) held by or on behalf of any other employee benefit plans maintained by the same employer (or affiliate thereof as defined in PTE 95-60) or by the same employee organization in the
general account do not exceed 10% of the total reserves and liabilities of the general account (exclusive of separate account liabilities) plus surplus as set forth in the NAIC Annual Statement filed with such Initial Purchaser’s state of
domicile; 
 (b) the Source is a separate account that is maintained solely in connection with such Initial Purchaser’s fixed
contractual obligations under which the amounts payable, or credited, to any employee benefit plan (or its related trust) that has any interest in such separate account (or to any participant or beneficiary of such plan (including any annuitant))
are not affected in any manner by the investment performance of the separate account; 
 (c) the Source is either (i) an insurance
company pooled separate account, within the meaning of PTE 90-1 or (ii) a bank collective investment fund, within the meaning of the PTE 91-38 and, except
as disclosed by such Initial Purchaser to the Borrower in writing pursuant to this clause (c), no employee benefit plan or group of plans maintained by the same employer or employee organization beneficially owns more than 10% of all
assets allocated to such pooled separate account or collective investment fund; 
 (d) the Source constitutes assets of an “investment
fund” (within the meaning of Part VI of PTE 84-14 (the “QPAM Exemption”)) managed by a “qualified professional asset manager” or “QPAM” (within the meaning of
Part VI of the QPAM Exemption), no employee benefit plan’s assets that are managed by the QPAM in such investment fund, when combined with the assets of all other employee benefit plans established or maintained by the same employer or by an
affiliate (within the meaning of Part VI(c)(1) of the QPAM Exemption) of such employer or by the same employee organization and managed by such QPAM, represent more than 20% of the total client assets managed by such QPAM, the conditions of
Part I(c) and (g) of the QPAM Exemption are satisfied, neither the QPAM nor a person controlling or controlled by the QPAM maintains an ownership interest in the Borrower that would cause the QPAM and the Borrower to be “related”
within the meaning of Part VI(h) of the QPAM Exemption and (i) the identity of such QPAM and (ii) the names of any employee benefit plans whose assets in the investment fund, when combined with the assets of all other employee benefit
plans established or maintained by the same employer or by an affiliate (within the meaning of Part VI(c)(1) of the QPAM Exemption) of such employer or by the same employee organization, represent 10% or more of the assets of such investment
fund, have been disclosed to the Borrower in writing pursuant to this clause (d); 
 (e) the Source constitutes assets of a
“plan(s)” (within the meaning of Part IV(h) of PTE 96-23 (the “INHAM Exemption”)) managed by an “in-house asset manager” or
“INHAM” (within the meaning of Part IV(a) of the INHAM Exemption), the conditions of Part I(a), (g) and (h) of the INHAM Exemption are satisfied, neither the INHAM nor a person controlling or controlled by the INHAM (applying the
definition of “control” in Part IV(d)(3) of the INHAM Exemption) owns a 10% or more interest in the Borrower and (i) the identity of such INHAM and (ii) the name(s) of the employee benefit plan(s) whose assets constitute the
Source have been disclosed to the Borrower in writing pursuant to this clause (e); 

  
 - 8 - 

 (f) the Source is a governmental plan; 

(g) the Source is one or more employee benefit plans, or a separate account or trust fund comprised of one or more employee benefit plans,
each of which has been identified to the Borrower in writing pursuant to this clause (g); or 
 (h) the Source does not include assets of
any employee benefit plan, other than a plan exempt from the coverage of ERISA. 
 As used in this Section 6.2,
the terms “employee benefit plan,” “governmental plan,” and “separate account” shall have the respective meanings assigned to such terms in Section 3 of ERISA. 

Section 6.3 Notes Documents. By its acceptance of a Note, each Purchaser thereby agrees to the terms of the Notes, the Note
Purchase Agreement, the Common Terms Agreement, the Pledge and Security Agreement and the Intercreditor Agreement and, solely to the extent applicable, agrees to be bound by the obligations of holders of Notes (or beneficial owners thereof)
contained therein. 
 ARTICLE 7 

PAYMENT OF THE NOTES 

Section 7.1 Payment; Maturity. 

(a) The entire unpaid principal balance of the Notes shall be due and paid at par and without payment of the Make-Whole Amount, or any
premium, on the stated Maturity Date thereof. Any Additional Senior Notes shall be payable in accordance with the terms of the applicable Supplement. 

(b) Each partial prepayment of the Notes (i) pursuant to Section 7.2 shall be applied to prepay the principal
of the Initial Notes, and any installments of principal of any Additional Senior Notes, in order of maturity, and (ii) pursuant to Section 7.5 shall be applied to prepay the principal of the Initial Notes set forth on
Schedule 7.1 that have elected to be redeemed and any installments of principal of any Additional Senior Notes that have elected to be redeemed in order of maturity. 

(c) Interest on each Note shall be paid in accordance with the terms thereof. 

Section 7.2 Optional Prepayments with Make-Whole Amount. The Borrower may, at its option, upon notice as provided below,
prepay at any time all, or from time to time any part of, the Notes of any one or more Series, in an amount not less than $3,500,000 or a whole multiple of $500,000 in excess thereof, or if less, the entire principal amount thereof then outstanding,
at 100% of the principal amount so prepaid, together with unpaid interest accrued 

  
 - 9 - 

 
thereon to the date of such prepayment, and, if such prepayment occurs on or prior to the date that is one-hundred twenty (120) days prior to the
Maturity Date for such Series of Notes, the Make-Whole Amount determined for the prepayment date with respect to such principal amount. The Borrower will give each holder of Notes written notice of each
optional prepayment under this Section 7.2 not less than twenty (20) days and not more than sixty (60) days prior to the date fixed for such prepayment (unless the Borrower and the Required FRN Holders agree to
another time period). Each such notice shall specify such date, the aggregate principal amount of the Notes to be prepaid on such date, the principal amount of each Note held by such holder to be prepaid (determined in accordance with
Section 7.3), and the interest to be paid on the prepayment date with respect to such principal amount being prepaid, and shall be accompanied by an Officer’s Certificate as to the estimated Make-Whole Amount due in
connection with such prepayment (calculated as if the date of such notice were the date of the prepayment), setting forth the details of such computation. Two (2) Business Days prior to such prepayment, the Borrower shall deliver to each holder
of Notes an Officer’s Certificate specifying the calculation of such Make-Whole Amount as of the specified prepayment date. 

Section 7.3 Allocation of Partial Prepayments. In the case of each partial prepayment of the Notes of any Series pursuant to
Section 7.2, the principal amount of the Notes of such Series to be prepaid shall be allocated pro rata among all the Notes at the time outstanding in proportion, as nearly as practicable, to the respective unpaid principal
amounts of the Notes of such Series not theretofore called for prepayment. 
 Section 7.4 Maturity; Surrender, Etc. In the case
of each optional prepayment of Notes of any Series pursuant to Section 7.2, the principal amount of each Note to be prepaid shall mature and become due and payable on the date fixed for such prepayment (which shall be a
Business Day), together with interest on such principal amount accrued to such date and the applicable Make-Whole Amount, if any. From and after such date, unless the Borrower shall fail to pay such principal
amount when so due and payable, together with the interest and Make-Whole Amount, if any, as aforesaid, interest on such principal amount shall cease to accrue. Any Note paid or prepaid in full shall be surrendered to the Borrower and cancelled and
shall not be reissued, and no Note shall be issued in lieu of any prepaid principal amount of any Note. 
 Section 7.5 Mandatory
Offers to Prepay. The Borrower shall be required to offer to prepay the Notes as and to the extent required pursuant to Sections 3.3 and 3.4 of the Common Terms Agreement. 

Section 7.6 Purchase of Notes. The Borrower will not and will not permit any Affiliate to purchase, redeem, prepay or otherwise
acquire, directly or indirectly, any of the outstanding Notes except (a) upon the redemption, payment or prepayment by the Borrower of the Notes in accordance with the terms of this Agreement, the Common Terms Agreement and the Notes or
(b) pursuant to a call for tenders given by the Borrower to all holders of the Notes by notice given in accordance with Section 18, which notice shall specify the purchase date (which shall not be earlier than fifteen
(15) days after the giving of such notice), the purchase price and the place of payment thereof. Any such call for tenders in respect of clause (b) shall provide that the terms and conditions for such purchase shall be the same for all
Notes except to the extent that the respective purchase prices differ for different Series of Notes as a result of differences in interest rates or payment or Maturity Dates. If an aggregate principal amount of the Notes is

  
 - 10 - 

 
tendered in respect of clause (b) which is greater than that offered to be purchased, such tendered Notes shall be purchased on a pro rata basis in the proportion, as nearly as
practicable, which the principal amount of Notes tendered by each holder bears to the principal amount of Notes tendered by all holders of Notes and, if applicable, in order of maturity to all scheduled amortizations. The Borrower will promptly
cancel all Notes acquired by the Borrower or any Affiliate pursuant to any tender, redemption, payment or prepayment of Notes pursuant to any provision of this Agreement and no Notes may be issued in substitution or exchange for any such Notes. 

Section 7.7 Make-Whole Amount. The term “Make-Whole Amount” means, with respect to any Initial Note, an amount
equal to the excess, if any, of the Discounted Value of the Remaining Scheduled Payments with respect to the Called Principal of such Note over the amount of such Called Principal; provided that the Make-Whole Amount may in no event be less
than zero. For the purposes of determining the Make-Whole Amount, the following terms have the following meanings: 

“Called Principal” means, with respect to any Initial Note, the principal of such Initial Note that is to be
prepaid pursuant to Section 7.2 or has become or is declared to be immediately due and payable pursuant to Section 10 of the Common Terms Agreement, as the context requires. 

“Discounted Value” means, with respect to the Called Principal of any Initial Note, the amount obtained by
discounting all Remaining Scheduled Payments with respect to such Called Principal from their respective scheduled due dates to the Settlement Date with respect to such Called Principal, in accordance with accepted financial practice and at a
discount factor (applied on the same periodic basis as that on which interest on such Initial Note is payable) equal to the Reinvestment Yield with respect to such Called Principal. 

“Reinvestment Yield” means, with respect to the Called Principal of any Initial Note, 0.50% over the yield to
maturity implied by the yield(s) reported as of 10:00 a.m. (New York City time) on the second Business Day preceding the Settlement Date with respect to such Called Principal, on the display designated as “Page PX1” (or such other
display as may replace Page PX1) on Bloomberg Financial Markets for the most recently issued actively traded on-the-run U.S. Treasury securities
(“Reported”) having a maturity equal to the Remaining Average Life of such Called Principal as of such Settlement Date. If there are no such U.S. Treasury securities Reported having a maturity equal to such Remaining Average
Life, then such implied yield to maturity will be determined by (a) converting U.S. Treasury bill quotations to bond equivalent yields in accordance with accepted financial practice and (b) interpolating linearly between the yields
Reported for the applicable most recently issued actively traded on-the-run U.S. Treasury securities with the maturities (1) closest to and greater than such
Remaining Average Life and (2) closest to and less than such Remaining Average Life. The Reinvestment Yield shall be rounded to the number of decimal places as appears in the interest rate of the applicable Initial Note. 

If such yields are not Reported or the yields Reported as of such time are not ascertainable (including by way of interpolation), then
“Reinvestment Yield” means, with respect to the Called Principal of any Initial Note, 0.50% over the yield to maturity implied by the U.S. Treasury constant maturity yields reported, for the latest day for which such yields

  
 - 11 - 

 
have been so reported as of the second Business Day preceding the Settlement Date with respect to such Called Principal, in Federal Reserve Statistical Release H.15 (or any comparable successor
publication) for the U.S. Treasury constant maturity having a term equal to the Remaining Average Life of such Called Principal as of such Settlement Date. If there is no such U.S. Treasury constant maturity having a term equal to such
Remaining Average Life, such implied yield to maturity will be determined by interpolating linearly between (1) the U.S. Treasury constant maturity so reported with the term closest to and greater than such Remaining Average Life and
(2) the U.S. Treasury constant maturity so reported with the term closest to and less than such Remaining Average Life. The Reinvestment Yield shall be rounded to the number of decimal places as appears in the interest rate of the
applicable Initial Note. 
 “Remaining Average Life” means, with respect to any Called Principal, the number
of years obtained by dividing (i) such Called Principal into (ii) the sum of the products obtained by multiplying (a) the principal component of each Remaining Scheduled Payment with respect to such Called Principal by (b) the
number of years, computed on the basis of a 360-day year composed of twelve 30-day months and calculated to two decimal places, that will elapse between the
Settlement Date with respect to such Called Principal and the scheduled due date of such Remaining Scheduled Payment. 

“Remaining Scheduled Payments” means, with respect to the Called Principal of any Initial Note, all payments
of such Called Principal and interest thereon that would be due after the Settlement Date with respect to such Called Principal if no payment of such Called Principal were made prior to its scheduled due date; provided that if such Settlement
Date is not a date on which interest payments are due to be made under the terms of such Initial Note, then the amount of the next succeeding scheduled interest payment will be reduced by the amount of interest accrued to such Settlement Date and
required to be paid on such Settlement Date pursuant to Section 7.2, Section 9 of the Common Terms Agreement. 

“Settlement Date” means, with respect to the Called Principal of any Initial Note, the date on which such
Called Principal is to be prepaid pursuant to Section 7.2 or has become or is declared to be immediately due and payable pursuant to Section 9 of the Common Terms Agreement, as the context requires. 

The term “Make-Whole Amount” means, with respect to any Additional Senior Notes, an amount calculated as set forth in
the Supplement pursuant to which such Additional Senior Notes are issued. 
 Section 7.8 Payments Due on Non-Business Days. Anything in this Agreement, the Common Terms Agreement or the Notes to the contrary notwithstanding, (a) subject to clause (b) of this Section, any payment of interest
on any Note that is due on a date that is not a Business Day shall be made on the next succeeding Business Day without including the additional days elapsed in the computation of the interest payable on such next succeeding Business Day, and
(b) any payment of principal of or Make-Whole Amount on any Note (including principal due on any scheduled repayment date or the maturity date of such Note) that is due on a date that is not a Business Day shall be made on the next succeeding
Business Day and shall include the additional days elapsed in the computation of interest payable on such next succeeding Business Day. 

  
 - 12 - 

 ARTICLE 8 

AFFIRMATIVE COVENANTS 

Section 8.1 Affirmative Covenants of the Borrower. The Borrower agrees with each holder of Notes that it will perform or observe
(as applicable) the obligations set forth in Sections 6 and 7 of the Common Terms Agreement in accordance with the terms thereof. 

Section 8.2 Ratings. The Borrower covenants that so long as any of the Notes are outstanding it shall use commercially reasonable
efforts to maintain a rating (but not any particular rating) from a Rating Agency in respect of the Notes. 
 ARTICLE 9 

NEGATIVE COVENANTS 

Section 9.1 Negative Covenants of the Borrower. The Borrower agrees with each holder of the Notes that it will perform or
observe (as applicable) the obligations set forth in Section 8 of the Common Terms Agreement in accordance with the terms thereof. 

ARTICLE 10 
 EVENTS OF
DEFAULT 
 The occurrence of any Event of Default set forth in Section 9 of the Common Terms Agreement shall constitute an “Event of
Default” hereunder. 
 ARTICLE 11 

RESCISSION 

Section 11.1 Rescission. At any time after any Notes have been declared due and payable following an Event of Default under
Section 9(a) of the Common Terms Agreement, the Required FRN Holders by written notice to the Borrower, may rescind and annul any such declaration and its consequences if (a) the Borrower has paid all overdue interest on the Notes, all
principal of and Make-Whole Amount, if any, on any Notes that are due and payable and are unpaid other than by reason of such declaration, and all interest on such overdue principal and Make-Whole Amount, if any, and (to the extent permitted by
applicable law) any overdue interest in respect of the Notes, at the applicable Default Rate, (b) all Events of Default and Defaults, other than non-payment or amounts that have become due solely by
reason of such declaration, have been cured or have been waived pursuant to Section 11.1 of the Common Terms Agreement and (c) no judgment or decree has been entered for the payment of any monies due pursuant hereto or to the Notes. No
rescission and annulment under this Article 11 will extend to or affect any subsequent Event of Default or Default or impair any right consequent thereon. 

  
 - 13 - 

 ARTICLE 12 

REGISTRATION; EXCHANGE; SUBSTITUTION OF NOTES 

Section 12.1 Registration of Notes. The Borrower shall keep at its principal executive office a register for the registration and
registration of transfers of Notes. The name and address of each holder of one or more Notes, each transfer thereof and the name and address of each transferee of one or more Notes shall be registered in such register. If any holder of one or more
Notes is a nominee, then (a) the name and address of the beneficial owner of such Note or Notes shall also be registered in such register as an owner and holder thereof and (b) at any such beneficial owner’s option, either such
beneficial owner or its nominee may execute any amendment, waiver or consent pursuant to this Agreement or any other Credit Document. Prior to due presentment for registration of transfer, the Person in whose name any Note shall be registered shall
be deemed and treated as the owner and holder thereof for all purposes hereof, and the Borrower shall not be affected by any notice or actual knowledge to the contrary. The Borrower shall give to any holder of a Note that is an Institutional
Investor promptly upon request therefor, a complete and correct copy of the names and addresses of all registered holders of Notes. 

Section 12.2 Transfer and Exchange of Notes. Upon surrender of any Note to the Borrower at the address and to the attention of
the designated officer (all as specified in Article 17) for registration of transfer or exchange (and in the case of a surrender for registration of transfer accompanied by a written instrument of transfer duly
executed by the registered holder of such Note or such holder’s attorney duly authorized in writing and accompanied by the relevant name, address and other information for notices of each transferee of such Note or part thereof), within ten
(10) Business Days thereafter, the Borrower shall execute and deliver, at the Borrower’s expense (except as provided below), one or more new Notes of the same Series (as requested by the holder thereof) in exchange therefor, in an
aggregate principal amount equal to the unpaid principal amount of the surrendered Note. Each such new Note shall be payable to such Person as such holder may request and shall be substantially in the form of Schedule 1, in
the case of the Initial Notes, or the note form established for the applicable Series. Each such new Note shall be dated and bear interest from the date to which interest shall have been paid on the surrendered Note or dated the date of the
surrendered Note if no interest shall have been paid thereon. The Borrower may require payment of a sum sufficient to cover any stamp Tax or governmental charge imposed in respect of any such transfer of Notes. Notes shall not be transferred in
denominations of less than $100,000; provided that if necessary to enable the registration of transfer by a holder of its entire holding of Notes of a Series, one Note of such Series may be in a denomination of less than $100,000. In
connection with any transfer of Notes, the transferee shall enter into a Joinder substantially in the form attached to the Common Terms Agreement as Exhibit G and an accession agreement to the Intercreditor Agreement. Any transferee, by its
acceptance of a Note registered in its name (or the name of its nominee), shall be deemed to have made the representations set forth in Section 6.2. 

Section 12.3 Replacement of Notes. Upon receipt by the Borrower at the address and to the attention of the designated officer
(all as specified in Article 17) of evidence reasonably satisfactory to it of the ownership of and the loss, theft, destruction or mutilation of any Note (which evidence shall be, in the case of an Institutional Investor,
notice from such Institutional Investor of such ownership and such loss, theft, destruction or mutilation), and 

  
 - 14 - 

 (a) in the case of loss, theft or destruction, of indemnity reasonably satisfactory to it
(provided that if the holder of such Note is, or is a nominee for, an original Purchaser or another holder of a Note with a minimum net worth of at least $50,000,000 or a Qualified Institutional Buyer, such Person’s own unsecured agreement of
indemnity shall be deemed to be satisfactory), or 
 (b) in the case of mutilation, upon surrender and cancellation thereof, within ten
(10) Business Days thereafter, the Borrower at its own expense shall execute and deliver, in lieu thereof, a new Note of the same Series, dated and bearing interest from the date to which interest shall have been paid on such lost, stolen,
destroyed or mutilated Note or dated the date of such lost, stolen, destroyed or mutilated Note if no interest shall have been paid thereon. 

ARTICLE 13 
 PAYMENT ON
NOTES 
 Section 13.1 Place of Payment. Subject to Section 13.2, payments of principal,
Make-Whole Amount, if any, and interest becoming due and payable on the Notes shall be made in accordance with Section 13.2. The Borrower may at any time, by notice to each holder of a Note, change the place of payment of
the Notes so long as such place of payment shall be either the principal office of the Borrower in such jurisdiction or the principal office of a bank or trust company in such jurisdiction. 

Section 13.2 Home Office Payment. So long as any Purchaser or its nominee shall be the holder of any Note, and
notwithstanding anything contained in Section 13.1 or in such Note to the contrary, the Borrower will pay all sums becoming due on such Note for principal, Make-Whole Amount, if any,
interest and all other amounts becoming due hereunder by the method and at the address specified for such purpose below such Purchaser’s name in Schedule B hereto or applicable Supplement or by such other method
or at such other address as such Purchaser shall have from time to time specified to the Borrower in writing for such purpose, without the presentation or surrender of such Note or the making of any notation thereon, except that upon written request
of the Borrower made concurrently with or reasonably promptly after payment or prepayment in full of any Note, such Purchaser shall surrender such Note for cancellation, reasonably promptly after any such request, to the Borrower at its principal
executive office or at the place of payment most recently designated by the Borrower pursuant to Section 13.1. Prior to any sale or other disposition of any Note held by a Purchaser or its nominee, such Purchaser will, at
its election, either endorse thereon the amount of principal paid thereon and the last date to which interest has been paid thereon or surrender such Note to the Borrower in exchange for a new Note pursuant to Section 12.2.
The Borrower will afford the benefits of this Section 13.2 to any Institutional Investor that is the direct or indirect transferee of any Note purchased by a Purchaser under this Agreement and that has made the same
agreement relating to such Note as the Purchasers have made in this Section 13.2. 

  
 - 15 - 

 ARTICLE 14 

EXPENSES, ETC. 

Section 14.1 Transaction Expenses. The Borrower shall pay the costs and expenses of and indemnify the Purchasers
and Holders as and to the extent set forth in Section 11.5 of the Common Terms Agreement. 
 Section 14.2 Survival. The
obligations of the Borrower under this Article 14 will survive the payment or transfer of any Note, the enforcement, amendment or waiver of any provision of this Agreement or the Credit Documents, and the termination of
this Agreement and the Credit Documents. 
 ARTICLE 15 

SURVIVAL OF REPRESENTATIONS AND WARRANTIES; ENTIRE AGREEMENT 

All representations and warranties contained herein or in any Credit Document shall survive the execution and delivery of this Agreement and
the Notes, the purchase or transfer by any Purchaser of any Note or portion thereof or interest therein and the payment of any Note, and may be relied upon by any subsequent holder of a Note, regardless of any investigation made at any time by or on
behalf of such Purchaser or any other holder of a Note. All statements contained in any certificate or other instrument delivered by or on behalf of the Borrower pursuant to this Agreement and the Common Terms Agreement shall be deemed
representations and warranties of the Borrower under this Agreement. Subject to the preceding sentence, this Agreement, the Notes and the other Credit Documents embody the entire agreement and understanding between each Purchaser and the Borrower
and supersede all prior agreements and understandings relating to the subject matter hereof. 
 ARTICLE 16 

AMENDMENTS AND WAIVERS 

Section 16.1 Requirements. Subject to Section16.4, this Agreement and the Notes may be amended, and the observance of any
term hereof or of the Notes may be waived (either retroactively or prospectively), with (and only with) the written consent of the Borrower and the Required FRN Holders, and notwithstanding any provision of the Common Terms Agreement or any other
Credit Document to the contrary, no consent of any other Secured Party will be required for any such amendment, waiver or modification, except that: 

(a) no amendment or waiver of any of the provisions of Article 1, 2, 3, 4, 6
or 20 hereof, or any defined term (as it is used therein), will be effective as to any Purchaser unless consented to by such Purchaser in writing; and 

(b) no amendment or waiver may, without the written consent of the holder of each Note at the time outstanding and affected thereby,
(i) subject to the provisions of Article 10 of the Common Terms Agreement relating to acceleration or rescission, change the amount or time of any prepayment or payment of principal of, or reduce the rate or change the time of payment or method
of computation of interest on the Notes or of the Make-Whole Amount in respect of the Notes, (ii) change the percentage of the principal amount of the Notes the holders of which are required to consent to any amendment or waiver,
(iii) amend any of Article 7 hereof, 

  
 - 16 - 

 
this Article 16, Sections 10 and 11.14 of the Common Terms Agreement or (iv) release all or substantially all of the Collateral from the Lien of the Security Documents.
Notwithstanding any provision of this Section 16.1 to the contrary, any provision of the Common Terms Agreement incorporated by reference in this Agreement and amended or waived in accordance with the terms of the Common
Terms Agreement shall be deemed waived or amended for purposes of this Agreement. 
 Notwithstanding anything to the contrary contained herein, the Borrower
may enter into any Supplement for the issuance of one or more Series of Additional Notes consistent with Section 1.2 hereof without obtaining the consent of any holder of any other Series of Notes. 

Section 16.2 Solicitation of Holders of Notes. 

(a) Solicitation. The Borrower will provide each holder of the Notes (irrespective of the amount of Notes then owned by it) with
sufficient information, sufficiently far in advance of the date a decision is required, to enable such holder to make an informed and considered decision with respect to any proposed amendment, waiver or consent in respect of any of the provisions
hereof or of the Credit Documents. The Borrower will deliver executed or true and correct copies of each amendment, waiver or consent effected pursuant to the provisions of this Article 16 to each holder of
outstanding Notes promptly following the date on which it is executed and delivered by, or receives the consent or approval of, the requisite holders of Notes. 

(b) Payment. The Borrower will not directly or indirectly pay or cause to be paid any remuneration, whether by way of supplemental or
additional interest, fee or otherwise, or grant any security or provide other credit support, to any holder of any Notes as consideration for or as an inducement to the entering into by any holder of Notes of any waiver or amendment of any of the
terms and provisions hereof or any other Credit Document unless such remuneration is concurrently paid, or security is concurrently granted or other credit support concurrently provided, on the same terms, ratably to the holders of each Note then
outstanding even if such holder did not consent to, or have a right to consent to, such waiver or amendment. 
 (c) Consent in
Contemplation of Transfer. Any consent given pursuant to this Article 16 by a holder of a Note (other than an Affiliate of the Borrower) that has transferred or has agreed to transfer its Note to the Borrower or any
Affiliate of the Borrower in connection with such consent shall be void and of no force or effect except solely as to such holder, and any amendments effected or waivers granted or to be effected or granted that would not have been or would not be
so effected or granted but for such consent (and the consents of all other holders of Notes that were acquired under the same or similar conditions) shall be void and of no force or effect except solely as to such holder. 

Section 16.3 Binding Effect, Etc. Any amendment or waiver consented to as provided in this
Article 16 applies equally to all holders of Notes and is binding upon them and upon each future holder of any Note and upon the Borrower without regard to whether such Note has been marked to indicate such amendment or
waiver. No such amendment or waiver will extend to or affect any obligation, covenant, agreement, Default or Event of Default not expressly amended or waived or impair any right consequent thereon. No course of dealing between the Borrower and the
holder of any Note nor any delay in exercising any rights hereunder or under any Note or any Credit Document shall operate as a waiver of any rights of any holder of Notes. 

  
 - 17 - 

 Section 16.4 Notes Held by the Obligors,
Etc. Solely for the purpose of determining whether the holders of the requisite percentage of the aggregate principal amount of Notes then outstanding approved or consented to any amendment, waiver or consent to be given
under this Agreement or the Credit Documents, or have directed the taking of any action provided herein or in the Credit Documents to be taken upon the direction of the holders of a specified percentage of the aggregate principal amount of Notes
then outstanding, Notes directly or indirectly owned by any Obligor or any of their respective Affiliates shall be deemed not to be outstanding, other than with respect to (a) matters set forth in Sections 16.1(a) (as it relates to
Articles 6 and 20) and (b)(i) and (b) matters set forth in Section 11.1(g) of the Common Terms Agreement to the extent provided therein. 

ARTICLE 17 
 NOTICES

 All notices and communications provided for hereunder shall be given or made as specified pursuant to Section 11.2 of the Common
Terms Agreement. 
 ARTICLE 18 

REPRODUCTION OF DOCUMENTS 

This Agreement and all documents relating thereto (except certificates of Equity Interests in the Borrower and any other Collateral delivered
to the Collateral Agent), including, without limitation, (a) consents, waivers and modifications that may hereafter be executed, (b) documents received by any Initial Purchaser at the NPA Funding Date (except the Initial Notes) and
(c) financial statements, certificates and other information previously or hereafter furnished to any Purchaser, may be reproduced by such Purchaser by any photographic, photostatic, electronic, digital or other similar process and such
Purchaser may destroy any original document so reproduced. The Borrower agrees and stipulates that, to the extent permitted by Applicable Law, any such reproduction shall be admissible in evidence as the original itself in any judicial or
administrative proceeding (whether or not the original is in existence and whether or not such reproduction was made by such Purchaser in the regular course of business) and any enlargement, facsimile or further reproduction of such reproduction
shall likewise be admissible in evidence. This Article 18 shall not prohibit the Borrower or any other holder of Notes from contesting any such reproduction to the same extent that it could contest the original, or from
introducing evidence to demonstrate the inaccuracy of any such reproduction. 
 ARTICLE 19 

CONFIDENTIAL INFORMATION 

The provisions of Section 11.14 of the Common Terms Agreement are hereby incorporated herein by reference as if fully set forth herein.

  
 - 18 - 

 Each holder of a Note, by its acceptance of a Note, will be deemed to have agreed to be
bound by and to be entitled to the benefits of this Article 19 as though it were a party to this Agreement. On reasonable request by the Borrower in connection with the delivery to any holder of a Note of information
required to be delivered to such holder under this Agreement or requested by such holder (other than a holder that is a party to this Agreement or its nominee), such holder will enter into an agreement with the Borrower embodying the provisions of
this Article 19. Notwithstanding anything herein to the contrary, except as reasonably necessary to comply with applicable securities laws, a Purchaser may disclose to any and all persons, without limitation of any kind,
the U.S. federal or state income Tax treatment and Tax Structure of the Notes and all materials of any kind (including opinions and other Tax analyses) that are provided to the Purchaser related to such Tax treatment and Tax Structure. For this
purpose, “Tax Structure” means any facts relevant to the U.S. federal or state income Tax treatment of the Notes but does not include information relating to the identity of the Borrower. 

ARTICLE 20 
 SUBSTITUTION
OF PURCHASER 
 Each Purchaser shall have the right to substitute any one of its Affiliates or another Purchaser or any one of such
other Purchaser’s Affiliates (a “Substitute Purchaser”) as the purchaser of the Notes that it has agreed to purchase hereunder, by written notice to the Borrower, which notice shall be signed by both such Purchaser and such
Substitute Purchaser, shall contain such Substitute Purchaser’s agreement to be bound by this Agreement, the Common Terms Agreement and the other Credit Documents and shall contain a confirmation by such Substitute Purchaser of the accuracy
with respect to it of the representations set forth in Article 6. Upon receipt of such notice, any reference to such Purchaser in this Agreement (other than in this Article 20), in the Common Terms
Agreement and in the other Credit Documents shall be deemed to refer to such Substitute Purchaser in lieu of such original Purchaser. In the event that such Substitute Purchaser is so substituted as a Purchaser hereunder and such Substitute
Purchaser thereafter transfers to such original Purchaser all of the Notes then held by such Substitute Purchaser, upon receipt by the Borrower of notice of such transfer, any reference to such Substitute Purchaser as a “Purchaser” in this
Agreement (other than in this Article 20), in the Common Terms Agreement and in the other Credit Documents shall no longer be deemed to refer to such Substitute Purchaser, but shall refer to such original Purchaser, and
such original Purchaser shall again have all the rights of an original holder of the Notes under this Agreement, in the Common Terms Agreement and in the other Credit Documents. 

ARTICLE 21 

MISCELLANEOUS 

Section 21.1 Successors and Assigns. All covenants and other agreements contained in this Agreement by or on behalf of any of the
parties hereto bind and inure to the benefit of their respective successors and assigns (including, without limitation, any subsequent holder of a Note) whether so expressed or not. 

  
 - 19 - 

 Section 21.2 Severability. Any provision of this Agreement that is prohibited
or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any
jurisdiction shall (to the full extent permitted by law) not invalidate or render unenforceable such provision in any other jurisdiction. 

Section 21.3 Construction, Etc. Each covenant contained herein shall be construed (absent express provision to the
contrary) as being independent of each other covenant contained herein, so that compliance with any one covenant shall not (absent such an express contrary provision) be deemed to excuse compliance with any other covenant. Where any provision herein
refers to action to be taken by any Person, or which such Person is prohibited from taking, such provision shall be applicable whether such action is taken directly or indirectly by such Person. 

For the avoidance of doubt, all Schedules and Exhibits attached to this Agreement shall be deemed to be a part hereof. 

Section 21.4 Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be an original but
all of which together shall constitute one instrument. Each counterpart may consist of a number of copies hereof, each signed by less than all, but together signed by all, of the parties hereto. 

Section 21.5 Governing Law. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AGREEMENT AND ANY DISPUTE OF
CLAIMS ARISING IN CONNECTION THEREWITH SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. 

Section 21.6 Jurisdiction and Process; Waiver of Jury Trial. The provisions of Section 11.12 of the Common
Terms Agreement are hereby incorporated herein by reference as if fully set forth herein, mutatis mutandis. 
 Section 21.7
Counsel. The Borrower has engaged Milbank, Tweed, Hadley & McCloy LLP (“Milbank”) as legal counsel to the Borrower. Subject to any independent agreement between Milbank and any Purchaser or any Affiliate of any
Purchaser, to the extent Milbank represents a Purchaser in matters unrelated to the transactions contemplated by this Agreement, such Purchaser hereby waives any conflict of interest that may exist due to Milbank’s representation of the
Borrower in the transactions contemplated hereby while simultaneously representing such Purchaser in such other unrelated matters. This waiver shall be binding on any holder of the Notes. Notwithstanding the foregoing, this waiver shall not extend
to any adversarial or other dispute resolution proceedings involving any Purchaser that is a Milbank client. Nothing herein is intended to modify the terms of any existing or future engagement of Milbank by any Purchaser or its Affiliate. 

[Remainder of Page Intentionally Left Blank] 

  
 - 20 - 

 If you are in agreement with the foregoing, please sign the form of agreement on a
counterpart of this Agreement and return it to the Borrower, whereupon this Agreement shall become a binding agreement between you and the Borrower. 
  

			
	 Very truly yours,

	
	 BATH COUNTY ENERGY, LLC

		
	 By:
	 	 /s/ Richard Roloff

		 	 Name: Richard Roloff

		 	 Title:   Senior Vice President

  
 Signature Page to Note
Purchase Agreement (Aspen Bath) 

 This Agreement is hereby accepted and agreed to as of the date hereof. 

 

			
	ALLIANZ LIFE INSURANCE COMPANY OF NORTH AMERICA
	 By: Allianz Global Investors U.S. LLC

As the authorized signatory and investment manager
 as
Purchaser

		
	By:	 	/s/ Charles J. Dudley
		 	Name: Charles J. Dudley
		 	Title:   Managing Director

  
 Signature Page to Note
Purchase Agreement (Aspen Bath) 

 This Agreement is hereby accepted and agreed to as of the date hereof. 

 

			
	 GENWORTH LIFE INSURANCE COMPANY,

as Purchaser

		
	By:	 	/s/ Stuart Shepetin
		 	Name: Stuart Shepetin
		 	Title:   Investment Officer

  
 Signature Page to Note
Purchase Agreement (Aspen Bath) 

 This Agreement is hereby accepted and agreed to as of the date hereof. 

 

			
	 GENWORTH LIFE AND ANNUITY INSURANCE COMPANY,

as Purchaser

		
	By:	 	/s/ Stuart Shepetin
		 	Name: Stuart Shepetin
		 	Title:   Investment Officer

  
 Signature Page to Note
Purchase Agreement (Aspen Bath) 

 This Agreement is hereby accepted and agreed to as of the date hereof. 

 

			
	 NATIONWIDE LIFE INSURANCE COMPANY,

as Purchaser

	
	 NATIONWIDE LIFE AND ANNUITY INSURANCE COMPANY,

as FRN Purchaser

		
	By:	 	/s/ Jason M. Comisar
		 	Name: Jason M. Comisar
		 	Title:   Authorized Signatory

  
 Signature Page to Note
Purchase Agreement (Aspen Bath) 

 This Agreement is hereby accepted and agreed to as of the date hereof. 

 

			
	 PACIFIC LIFE INSURANCE COMPANY,

as Purchaser

		
	By:	 	/s/ Matthew A. Levene
		 	Name: Matthew A. Levene
		 	Title:   Assistant Vice President
		
	By:	 	/s/ Peter S. Fiek
		 	Name: Peter S. Fiek
		 	Title:   Assistant Secretary

  
 Signature Page to Note
Purchase Agreement (Aspen Bath) 

 This Agreement is hereby accepted and agreed to as of the date hereof. 

 

			
	 TRANSAMERICA FINANCIAL LIFE INSURANCE COMPANY, by AEGON USA

Investment Management, LLC, its investment
manager

as Purchaser

		
	By:	 	/s/ Frederick B. Howard
		 	Name: Frederick B. Howard
		 	Title:   Vice President

  

			
	 TRANSAMERICA LIFE INSURANCE COMPANY, by AEGON USA Investment Management, LLC, its investment manager

as Purchaser

		
	By:	 	/s/ Frederick B. Howard
		 	Name: Frederick B. Howard
		 	Title:   Vice President

  
 Signature Page to Note
Purchase Agreement (Aspen Bath) 

 This Agreement is hereby accepted and agreed to as of the date hereof. 

 

			
	 TLIC RIVERWOOD REINSURANCE INC., by AEGON USA Investment Management, LLC, its investment manager

as Purchaser

		
	By:	 	/s/ Frederick B. Howard
		 	Name: Frederick B. Howard
		 	Title:   Vice President

  

			
	 TLIC IRONWOOD RE CORP, by AEGON USA Investment Management, LLC, its investment manager

as Purchaser

		
	By:	 	/s/ Frederick B. Howard
		 	Name: Frederick B. Howard
		 	Title:   Vice President

  
 Signature Page to Note
Purchase Agreement (Aspen Bath) 

 This Agreement is hereby accepted and agreed to as of the date hereof. 

 

			
	 AMERICAN FIDELITY ASSURANCE COMPANY INVESTMENT MASTER TRUST OF EXELIS INC.,

as Purchasers

	By: Voya Investment Management Co. LLC, as Agent
		
	By:	 	/s/ Fitzhugh L. Wickham III
		 	Name: Fitzhugh L. Wickham III
		 	Title: Vice President

  
 Signature Page to Note
Purchase Agreement (Aspen Bath) 

 This Agreement is hereby accepted and agreed to as of the date hereof. 

 

			
	 VOYA INSURANCE AND ANNUITY COMPANY

VOYA RETIREMENT INSURANCE AND ANNUITY COMPANY
 SECURITY LIFE OF
DENVER INSURANCE COMPANY
 RELIASTAR LIFE INSURANCE COMPANY

RELIASTAR LIFE INSURANCE COMPANY OF NEW YORK, as Purchasers

	By: Voya Investment Management LLC, as Agent
		
	By:	 	/s/ Fitzhugh L. Wickham III
		 	Name: Fitzhugh L. Wickham III
		 	Title: Vice President

  
 Signature Page to Note
Purchase Agreement (Aspen Bath) 

 This Agreement is hereby accepted and agreed to as of the date hereof. 

 

			
	 TEACHERS INSURANCE AND ANNUITY ASSOCIATION OF AMERICA,

as Purchaser

		
	By:	 	/s/ Joseph R. Cantey Jr.
		 	Name: Joseph R. Cantey Jr.
		 	Title:   Senior Director

  
 Signature Page to Note
Purchase Agreement (Aspen Bath) 

 This Agreement is hereby accepted and agreed to as of the date hereof. 

 

			
	 AMERICAN GENERAL LIFE INSURANCE
COMPANY

THE VARIABLE ANNUITY LIFE INSURANCE
COMPANY

	 By: AIG Asset Management (U.S.), LLC, as

Investment Adviser

 as Purchaser

		
	By:	 	/s/ John Pollock
		 	Name: John Pollock
		 	Title:   Managing Director

  
 Signature Page to Note
Purchase Agreement (Aspen Bath) 

 SCHEDULE B 

INFORMATION RELATING TO PURCHASERS 
  

			
	 Initial Purchaser
	  	 Principal Amount

	 ALLIANZ LIFE INSURANCE COMPANY OF NORTH AMERICA
  

Name in which Note is to be Registered: MAC & CO., LLC
  

Payment method: Wire transfer
  

Account Information:
  

Accompanying Information:
  

Name of Issuer:
  

_____________________________
 Description of Security:$_________
Series _________ Notes, due
 _________________________
  

PPN: [To be filled in by special counsel to investors] 

Due Date and Application (as among principal, make whole and interest) of the payment being made:

 
 Address for Notices:

 
 Allianz Life Insurance Company of North America

c/o Allianz Global Investors U.S. LLC
 Attn: Private
Placements
 55 Greens Farms Road
 Westport, CT 06880

Phone: 203-293-1900

Email: ppt@allianzgi.com
  

Instructions regarding delivery of new Notes:
  

The Depository Trust Company

570 Washington Blvd. – 5th Flr.

Jersey City, NJ 07310
 Tax
ID Number:
	  	$50,000,000.00

 Schedule B – 1 

			
	 AMERICAN GENERAL LIFE INSURANCE COMPANY
  

Name in which Note is to be registered:
  

HARE & CO., LLC
  

Payment method: Wire transfer
  

Account Information:
  

Address for Notices:
  

American General Life Insurance Company (886623)

c/o AIG Asset Management

2929 Allen Parkway, A36-04

Houston, Texas 77019-2155

Attn: PCG Investment Portfolio Support

Email: PPGIPS@aig.com
  

Duplicate payment notices (only) to:
  

American General Life Insurance Company (886623)
 c/o The Bank of
New York Mellon
 Attn: P & I Department

Email: aigteam@bnymellon.com
  

Physical delivery instructions:
  

DTCC
 570 Washington Blvd.

Jersey City, NJ 07310
 Attn: BNY Mellon / Branch Deposit
Department – 5th Floor
 Contact: Andre Granville

 
	  	$55,000,000.00
	 THE VARIABLE ANNUITY LIFE INSURANCE COMPANY
  

Name in which Note is to be registered:
  

HARE & CO., LLC
  

Payment method: Wire transfer
  
	  	$20,000,000.00

  
 2 

			
	 Account Information:
  

Address for Notices:
  

The Variable Annuity Life Insurance Company (260735)

c/o AIG Asset Management

2929 Allen Parkway, A36-04

Houston, Texas 77019-2155

Attn: PCG Investment Portfolio Support

Email: PPGIPS@aig.com
  

Duplicate payment notices (only) to:
  

The Variable Annuity Life Insurance Company (260735)
 c/o The Bank
of New York Mellon
 Attn: P & I Department
  

Fax: (718) 315-3076
  

Physical delivery instructions:
  

DTCC
 570 Washington Blvd.

Jersey City, NJ 07310
 Attn: BNY Mellon / Branch Deposit
Department – 5th Floor
 Contact: Andre Granville

 
	  	
	 GENWORTH LIFE INSURANCE COMPANY
  

Name in which Note is to be registered:
  

HARE & CO., LLC
  

Payment method: Wire transfer
  

Account Information:
  

Address for Notices:
  

Genworth Financial, Inc.

Account: Genworth Life Insurance Company 3001

Summer Street, 4th Floor

Stamford, CT 06905
 Attn:
Private Placements
 Telephone No: (203)708-3300

Fax No: (203)708-3308
	  	$11,000,000.00

  
 3 

			
	 Physical delivery instructions:

 
 The Depository Trust Co.

570 Washington Blvd.

BNY Mellon/Branch Deposit Dept. 5th Floor

Jersey City, NJ 07310
  
	  	
	 GENWORTH LIFE AND ANNUITY INSURANCE COMPANY
  

Name in which Note is to be registered:
  

HARE & CO., LLC
  

Payment method: Wire transfer
  

Account Information:
  

Address for Notices:
  

Genworth Financial, Inc.

Account: Genworth Life and Annuity Insurance Company

3001 Summer Street, 4thFloor

Stamford, CT 06905

Attn: Private Placements

Telephone No: (203)708-3300

Fax No: (203)708-3308

 
 Physical delivery instructions:

 
 The Bank of New York

570 Washington Blvd.

BNY Mellon/Branch Deposit Dept. 5th Floor

Jersey City, NJ 07310
  
	  	$4,000,000.00

  
 4 

			
	 NATIONWIDE LIFE INSURANCE COMPANY
  

Name in which Note is to be registered:
  

Nationwide Life Insurance Company
	  	$19,000,000.00

  

			
	 Payment method: Wire transfer
  

Account Information:
  

Address for Notices:

Nationwide Life Insurance Company

c/o The Bank of New York Mellon

Attn: P&I Department

P.O. Box 392003

Pittsburgh, PA 15251
  

With a copy to:
  

Nationwide Life Insurance Company

Nationwide Investments – Investment Operations

One Nationwide Plaza (1-05-401)

Columbus, Ohio 43215-2220
  

Physical delivery instructions:

The Depository Trust Company

570 Washington Blvd – 5th floor

Jersey City, NJ 07310

Attn: BNY Mellon/Branch Deposit Department

F/A/O Nationwide Life Insurance Co.
  
	  	
	 NATIONWIDE LIFE AND ANNUITY INSURANCE COMPANY
  

Name in which Note is to be registered:
  

Nationwide Life and Annuity Insurance Company
  

Payment method: Wire transfer
  

Account Information:
  

Address for Notices:
  

Nationwide Life and Annuity Insurance Company
 c/o The Bank of New
York Mellon
 Attn: P&I Department
 P.O. Box 392003

Pittsburgh, PA 15251
	  	$11,000,000.00

  
 5 

			
	 With a copy to:
  

Nationwide Life and Annuity Insurance Company

Nationwide Investments – Investment Operations

One Nationwide Plaza (1-05-401)

Columbus, Ohio 43215-2220
  

Physical delivery instructions:

The Depository Trust Company

570 Washington Blvd – 5th floor

Jersey City, NJ 07310

Attn: BNY Mellon/Branch Deposit Department

F/A/O Nationwide Life and Annuity Insurance Co.

 
	  	
	 PACIFIC LIFE INSURANCE COMPANY
  

Name in which Note is to be Registered: MAC & CO., as nominee for Pacific Life Insurance Company

 
 Payment method: Wire transfer

 
 Account Information:

 
 Address for Payment Notices:

 
 The Bank of New York Mellon

Attn: Pacific Life Accounting Team
 One Mellon Bank Center –
Room 1130
 Pittsburgh, PA 15258-0001
  

And
  

Pacific Life Insurance Company
 Attn: IM – Cash Team

700 Newport Center Drive
 Newport Beach, CA 92660

Fax: 949-718-5845

 
 Physical Delivery Instructions:

 
 The Depository Trust Company

Attn: BNY Mellon/Branch Deposit Department
 570 Washington Blvd
– 5th Floor
 Jersey City, NJ 07310
	  	$35,000,000.00

  
 6 

			
	 TEACHERS INSURANCE AND ANNUITY ASSOCIATION OF AMERICA
  

Payment method: Wire transfer through the Automated Clearing House System
  

Account Information:
  

Address for Payment Notices:
  

Teachers Insurance and Annuity Association of America
 730 Third
Avenue
 New York, New York 10017
 Attention: Securities
Accounting Division
 Phone: (212) 916-5504

 
 With a copy to:

 
 JPMorgan Chase Bank, N.A.

P.O. Box 35308
 Newark, New Jersey 07101

 
 And to:
  

Teachers Insurance and Annuity Association of America
 8500 Andrew
Carnegie Boulevard
 Charlotte, North Carolina 28262
 Attention:
Global Private Markets
 Telephone:   (704) 988-1000 (General Number)

Facsimile:    (704) 988-4916

Email: TIAAPrivatePlacements@tiaainvestments.com
  

Address for Other Notices:
  

Teachers Insurance and Annuity Association of America
 8500 Andrew
Carnegie Boulevard
 Charlotte, North Carolina 28262
 Attention:
Global Private Markets
 Telephone:   (704) 988-1000 (General Number)

Facsimile:    (704) 988-4916

Email: TIAAPrivatePlacements@tiaainvestments.com
	  	$30,000,000.00

  
 7 

			
	 Physical delivery instructions:
  

JPMorgan Chase Bank, N.A.
 4 Chase Metrotech Center

3rd Floor

Brooklyn, New York 11245-0001
 Attention: Physical Receive
Department
  
	  	
	 VOYA INSURANCE AND ANNUITY COMPANY
  

Payment method: Wire transfer
  

Account Information:
 For scheduled principal and interest
payments:
  
 For all payments other than scheduled principal and
interest:
  
 Address for Notices:

 
 Voya Investment Management LLC

5780 Powers Ferry Road NW, Suite 300
 Atlanta, GA 30327-4347

Attn: Operations/Settlements
 Email:
VoyaIMCashOperations@Voya.com
  
 Physical delivery instructions:

 
 The Depository Trust Company 
570 Washington Blvd – 5th floor 
Jersey City, NJ 07310 
Attn: BNY Mellon/Branch Deposit Department
	  	$4,100,000.00

  
 8 

			
	 VOYA INSURANCE AND ANNUITY COMPANY
  

Payment method: Wire transfer
  

Account Information:
 For scheduled principal and interest
payments:
  
 For all payments other than scheduled principal and
interest:
  
 Address for Notices:

 
 Voya Investment Management LLC

5780 Powers Ferry Road NW, Suite 300
 Atlanta, GA 30327-4347

Attn: Operations/Settlements
 Email:
VoyaIMCashOperations@Voya.com
  
 With a copy to:

 
 The Bank of New York

Insurance Trust Dept.
 101 Barclay 8 West

New York, NY 10286
 Attn.: Bailey Eng

 
 Physical delivery instructions:

 
 The Depository Trust Company 
570 Washington Blvd – 5th floor 
Jersey City, NJ 07310 
Attn: BNY Mellon/Branch Deposit Department
  
	  	$3,600,000.00
	 SECURITY LIFE OF DENVER INSURANCE COMPANY
  

Payment method: Wire transfer
  

Account Information:
  

For scheduled principal and interest payments:
  

For all payments other than scheduled principal and interest:
	  	$17,900,000.00

  
 9 

			
	 Address for Notices:
  

Voya Investment Management LLC
 5780 Powers Ferry Road NW, Suite
300
 Atlanta, GA 30327-4347
 Attn: Operations/Settlements

Email: VoyaIMCashOperations@Voya.com
  

Physical delivery instructions:
  

The Depository Trust Company 
570 Washington Blvd – 5th floor 
Jersey City, NJ 07310

Attn: BNY Mellon/Branch Deposit Department
  
	  	
	 RELIASTAR LIFE INSURANCE COMPANY
  

Payment method: Wire transfer
  

Account Information:
  

For scheduled principal and interest payments:
  

For all payments other than scheduled principal and interest:
  

Address for Notices:
  

Voya Investment Management LLC
 5780 Powers Ferry Road NW, Suite
300
 Atlanta, GA 30327-4347
 Attn: Operations/Settlements

Email: VoyaIMCashOperations@Voya.com
  

Physical delivery instructions:
  

The Depository Trust Company 
570 Washington Blvd – 5th floor 
Jersey City, NJ 07310

Attn: BNY Mellon/Branch Deposit Department
	  	$7,500,000.00

  
 10 

			
	 RELIASTAR LIFE INSURANCE COMPANY OF NEW YORK
  

Payment method: Wire transfer
  

Account Information:
  

For scheduled principal and interest payments:
  

For all payments other than scheduled principal and interest:
  

Address for Notices:
  

Voya Investment Management LLC
 5780 Powers Ferry Road NW, Suite
300
 Atlanta, GA 30327-4347
 Attn: Operations/Settlements

Email: VoyaIMCashOperations@Voya.com
  

Physical delivery instructions:
  

The Depository Trust Company 
570 Washington Blvd – 5th floor 
Jersey City, NJ 07310

Attn: BNY Mellon/Branch Deposit Department
	  	$300,000.00
		
	 VOYA RETIREMENT INSURANCE AND ANNUITY COMPANY
  

Payment method: Wire transfer
  

Account Information:
  

For scheduled principal and interest payments:
  

For all payments other than scheduled principal and interest:
	  	$7,600,000.00

  
 11 

			
	 Address for Notices:
  

Voya Investment Management LLC
 5780 Powers Ferry Road NW, Suite
300
 Atlanta, GA 30327-4347
 Attn: Operations/Settlements

Email: VoyaIMCashOperations@Voya.com
  

Physical delivery instructions:
  

The Depository Trust Company 
570 Washington Blvd – 5th floor 
Jersey City, NJ 07310

Attn: BNY Mellon/Branch Deposit Department
  
	  	
	 AMERICAN FIDELITY ASSURANCE COMPANY
  

Payment method: Wire transfer
  

Account Information:
  

Address for Notices:
  

Voya Investment Management LLC
 5780 Powers Ferry Road NW, Suite
300
 Atlanta, GA 30327-4347
 Attn: Operations/Settlements

Email: VoyaIMCashOperations@Voya.com
  

Physical delivery instructions:
  

InvesTrust N.A.
 5100 N. Classen Blvd.

Suite 620
 Oklahoma City, OK 73318

Attention: Debbie Sinard
	  	$6,000,000.00

  
 12 

			
	 INVESTMENT MASTER TRUST OF EXELIS INC.
  

Payment method: Wire transfer
  

Account Information:
  

Address for Notices:
  

BNYM Mellon Asset Servicing
 11486 Corporate Blvd., Suite 200

Orlando, FL 32817-8371
 Attn: Operations/Settlements

Email: VoyaTradeSupport@bnymellon.com
  

Physical delivery instructions:
  

The Northern Trust Company
 50 South LaSalle Street

Chicago, IL 60603
 Attn: Robert Draths

 
	  	$3,000,000.00
	 TRANSAMERICA FINANCIAL LIFE INSURANCE COMPANY
  

Payment method: Wire transfer
  

Account Information:
  

Address for Notices:
  

AEGON USA Investment Management, LLC
 Attn: -Privates Placements
MS 5335
 4333 Edgewood Road NE
 Cedar Rapids, IA 52499-5335

Email: privateplacements@aegonusa.com
  
	  	$3,000,000.00

  
 13 

			
	 TRANSAMERICA LIFE INSURANCE COMPANY
  

Payment method: Wire transfer
  

Account Information:
	  	$5,000,000.00

  

			
	 Address for Notices:
  

AEGON USA Investment Management, LLC

Attn: -Privates Placements MS 5335

4333 Edgewood Road NE

Cedar Rapids, IA 52499-5335

Email: privateplacements@aegonusa.com

 
	  	
	 TLIC RIVERWOOD REINSURANCE INC
  

Payment method: Wire transfer
  

Account Information:
  

Address for Notices:
  

AEGON USA Investment Management, LLC
 Attn: -Privates Placements
MS 5335
 4333 Edgewood Road NE
 Cedar Rapids, IA 52499-5335

Email: privateplacements@aegonusa.com
  
	  	$4,500,000.00
	 TLIC IRONWOOD RE CORP
  

Payment method: Wire transfer
  

Account Information:
  

Address for Notices:
  

AEGON USA Investment Management, LLC
 Attn: -Privates Placements
MS 5335
 4333 Edgewood Road NE
 Cedar Rapids, IA 52499-5335

Email: privateplacements@aegonusa.com
  
	  	$2,500,000.00
	Total:	  	$300,000,000.00

  
 14 

 SCHEDULE 11 

FORM OF INITIAL NOTES 

BATH COUNTY ENERGY, LLC 
 SENIOR
SECURED NOTE DUE 2033 
  

					
	No. [_________]	  		  	[Date]
	$[____________]	  		  	PPN [_____]

 FOR VALUE RECEIVED, the undersigned, BATH COUNTY ENERGY, LLC
(herein called the “Company”), a limited liability company organized and existing under the laws of the State of Delaware, hereby promises to pay to [__________], or its registered assigns, the principal sum of [_________]
DOLLARS (or so much thereof as shall not have been prepaid) on [___], 20332, (the “Maturity Date”), with interest (computed on the basis of a 360-day year of twelve 30-day months) on the unpaid balance hereof at the rate of (a) [_]% per annum from the date hereof, payable quarterly, on March 31,
June 30, September 30 and December 31 of each year, commencing on [_____]3, until the principal hereof shall have become due and payable, and on the Maturity Date, and (b) to
the extent permitted by law, on any overdue payment of interest and, during the continuance of an Event of Default, on such unpaid balance and on any overdue payment of any Make-Whole Amount, at a rate per
annum from time to time equal to the Default Rate. 
 Payments of principal of, interest on and any Make-Whole Amount with respect to this
Note are to be made in lawful money of the United States of America in New York, New York at the principal office of [__________] or at such other place as the Company shall have designated by written notice to the holder of this Note as provided in
the Note Purchase Agreement referred to below. 
 This Note is one of the Senior Secured Notes due 2033 (herein called the
“Notes”) issued pursuant to the Note Purchase Agreement dated as of December 11, 2017 (as amended, restated, renewed, replaced, supplemented or otherwise modified from time to time, the “Note Purchase
Agreement”), among the Company and the Purchasers party thereto from time to time and is entitled to the benefits thereof. Each holder of this Note will be deemed, by its acceptance hereof, to have (i) agreed to the confidentiality
provisions set forth in Section 19 of the Note Purchase Agreement and (ii) made the representations set forth in Section 6 of the Note Purchase Agreement. Unless otherwise indicated, capitalized terms used in this Note shall have the
respective meanings ascribed to such terms in the Note Purchase Agreement. 
  
  

 

	1 	 The interest rate included in this Note will be 4.58%, escalated by 1 basis point for each month delay in
funding for each such month from and after the fifth day of such month beginning March 5, 2018. 

	2 	 Fifteenth anniversary of the NPA Funding Date. 

	3 	 To reflect the last day of the first full calendar quarter following the NPA Funding Date.

  
 Schedule 1 – 1 

 THIS NOTE HAS NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, (THE
“ACT”) OR REGISTERED OR QUALIFIED UNDER THE SECURITIES LAWS OF
ANY STATE. THIS NOTE MAY NOT BE SOLD OR TRANSFERRED, IN THE
ABSENCE OF SUCH REGISTRATION OR QUALIFICATION OR AN EXEMPTION THEREFROM UNDER
THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. 

This Note is a registered Note and, as provided in the Note Purchase Agreement, upon surrender of this Note for registration of transfer, duly
endorsed, or accompanied by a written instrument of transfer duly executed by the registered holder hereof or such holder’s attorney duly authorized in writing, a new Note for a like principal amount will be issued to, and registered in the
name of, the transferee; provided that prior to such issuance of a new Note, to the extent such transferee is not already a party to the Intercreditor Agreement, such transferee shall have duly executed and delivered an Accession Agreement as
a Secured Party under the Intercreditor Agreement. Prior to due presentment for registration of transfer, the Company may treat the person in whose name this Note is registered as the owner hereof for the purpose of receiving payment and for all
other purposes, and the Company will not be affected by any notice to the contrary. 
 The Company will make required prepayments of
principal on the dates and in the amounts specified in the Note Purchase Agreement. This Note is also subject to optional prepayment, in whole or from time to time in part, at the times and on the terms specified in the Note Purchase Agreement, but
not otherwise. 
 If an Event of Default occurs and is continuing, the principal of this Note may be declared or otherwise become due and
payable in the manner, at the price (including any applicable Make-Whole Amount) and with the effect provided in the Note Purchase Agreement. 

This Note shall be construed and enforced in accordance with, and the rights of the Company and the holder of this Note shall be governed
by, the law of the State of New York. 

  
 Schedule 1 – 2 

 
			
	BATH COUNTY ENERGY, LLC
		
	By	 	 
		 	Name:
		 	Title:

  
 Schedule 1 – 3 

 SCHEDULE 2 

FORM OF ADDITIONAL SENIOR NOTES 

BATH COUNTY ENERGY, LLC 
 [___]%
SERIES [____] SENIOR NOTE DUE [_____], 2033 
  

					
	No. [_________]	  		  	[Date]
	$[____________]	  		  	PPN [_____]

 FOR VALUE RECEIVED, the undersigned, BATH COUNTY ENERGY, LLC
(herein called the “Company”), a limited liability company organized and existing under the laws of the State of Delaware, hereby promises to pay to [__________], or its registered assigns, the principal sum of [_________]
DOLLARS (or so much thereof as shall not have been prepaid) on [_____], (the “Maturity Date”), with interest (computed on the basis of [_____]) on the unpaid balance hereof at the rate of (a) [_]% per annum from
the date hereof, payable quarterly, on March 31, June 30, September 30 and December 31 of each year, commencing on [_____], until the principal hereof shall have become due and payable, and on the Maturity Date, and (b) to
the extent permitted by law, on any overdue payment of interest and, during the continuance of an Event of Default, on such unpaid balance and on any overdue payment of any Make-Whole Amount, at a rate per
annum from time to time equal to the Default Rate. 
 Payments of principal of, interest on and any Make-Whole Amount with respect to this
Note are to be made in lawful money of the United States of America in New York, New York at the principal office of [__________] or at such other place as the Company shall have designated by written notice to the holder of this Note as provided in
the Note Purchase Agreement referred to below. 
 This Note is one of a [__]% Series [____] Senior Note due [_____], 2033 (herein called the
“Notes”) issued pursuant to the Note Purchase Agreement dated as of [_____], 2017 (as amended, restated, renewed, replaced, supplemented or otherwise modified from time to time, the “Note Purchase Agreement”), among the Company
and the Purchasers party thereto from time to time and is entitled to the benefits thereof. Each holder of this Note will be deemed, by its acceptance hereof, to have (i) agreed to the confidentiality provisions set forth in Section 19 of
the Note Purchase Agreement and (ii) made the representations set forth in Section 6 of the Note Purchase Agreement. Unless otherwise indicated, capitalized terms used in this Note shall have the respective meanings ascribed to such terms
in the Note Purchase Agreement. 
 THIS NOTE HAS NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, (THE
“ACT”) OR REGISTERED OR QUALIFIED UNDER THE SECURITIES LAWS OF
ANY STATE. THIS NOTE MAY NOT BE SOLD OR TRANSFERRED, IN THE
ABSENCE OF SUCH REGISTRATION OR QUALIFICATION OR AN EXEMPTION THEREFROM UNDER
THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. 

  
 Schedule 3 – 1 

 This Note is a registered Note and, as provided in the Note Purchase Agreement, upon
surrender of this Note for registration of transfer, duly endorsed, or accompanied by a written instrument of transfer duly executed by the registered holder hereof or such holder’s attorney duly authorized in writing, a new Note for a like
principal amount will be issued to, and registered in the name of, the transferee; provided that prior to such issuance of a new Note, to the extent such transferee is not already a party to the Intercreditor Agreement, such transferee shall
have duly executed and delivered an Accession Agreement as a Secured Party under the Intercreditor Agreement. Prior to due presentment for registration of transfer, the Company may treat the person in whose name this Note is registered as the owner
hereof for the purpose of receiving payment and for all other purposes, and the Company will not be affected by any notice to the contrary. 

The Company will make required prepayments of principal on the dates and in the amounts specified in the Note Purchase Agreement. This Note is
also subject to optional prepayment, in whole or from time to time in part, at the times and on the terms specified in the Note Purchase Agreement, but not otherwise. 

If an Event of Default occurs and is continuing, the principal of this Note may be declared or otherwise become due and payable in the manner,
at the price (including any applicable Make-Whole Amount) and with the effect provided in the Note Purchase Agreement. 

This Note shall be construed and enforced in accordance with, and the rights of the Company and the holder of this Note shall be governed
by, the law of the State of New York. 

  
 Schedule 3 – 2 

 
			
	BATH COUNTY ENERGY, LLC
		
	By	 	 
		 	Name:
		 	Title:

  
 Schedule 3 – 3 

 SCHEDULE 3 

FORM OF SUPPLEMENT 
 BATH
COUNTY ENERGY, LLC 
 [________________________] 

[____________________] 
 As of
____________, _____ 
 To Each of the Purchasers 
 Named in the
Supplemental 
 Purchaser Schedule Attached 
 Hereto (the
“Supplemental Purchasers”) 
 Ladies and Gentlemen: 

Reference is made to that certain Note Purchase Agreement, dated December 11, 2017, among the Company and the Purchasers named therein (as
amended, restated, renewed, replaced, supplemented or otherwise modified from time to time, the “Agreement”). Terms used but not defined herein shall have the respective meanings set forth in the Agreement. 

As contemplated in Section 1.2 of the Agreement, the Company agrees with you as follows: 

A. Subsequent Series of Notes. The Company has authorized and will create a subsequent Series of Additional Senior Notes to be called
the “Series [__] Notes.” Said Series [__] Notes will be dated the date of issue; will bear interest (computed on the basis of [__]) from such date at the rate of [__] % per annum, payable [__] in arrears on the [__]th day of [__], [__], [__]and [__] in each year (commencing on [__]), until the principal amount thereof shall become due and payable and shall bear interest on overdue principal (including any overdue
optional prepayment of principal) and premium, if any, and, to the extent permitted by law, on any overdue installment of interest at the rate specified therein after the date due for payment, whether by acceleration or otherwise, until paid; will
be expressed to mature on [__]; and will be substantially in the form attached to the Agreement as Schedule 2 with the appropriate insertions to reflect the terms and provisions set forth above. 

B. Purchase and Sale of Series Notes. The Company hereby agrees to sell to each Supplemental Purchaser set forth on the Supplemental
Purchaser Schedule attached hereto as Schedule 1 (collectively, the “Series [__] Purchasers”) and, subject to the terms and conditions in the Agreement and herein set forth, each Series [_] Purchaser agrees to
purchase from the Company the aggregate principal amount of the Series [__] Notes set opposite each Series [__] Purchaser’s name in the Supplemental Purchaser Schedule at 100% of the aggregate principal amount. The sale of the Series [__]
Notes shall take place at the offices of [__],[__], at 10:00 

  
 Schedule 3 – 1 

 
a.m. New York time, at a closing the (“Series [__] Closing”) on [__], [__], or such other date as shall be agreed upon by the Company and each Series [__] Purchaser.
At the Series [__] Closing the Company will deliver to each Series [__] Purchaser one or more Series [__] Notes registered in such Series [__] Purchaser’s name (or in the name of its nominee), evidencing the aggregate principal
amount of Series [__] Notes to be purchased by said Series [__] Purchaser and in the denomination or denominations specified with respect to such Series [__] Purchaser in the Supplemental Purchaser Schedule attached hereto against payment of the
purchase price thereof by transfer of immediately available funds for credit to the Company’s account on the date of the Series ___ Closing (the “Series [__] Closing Date”) (as specified in a notice to each Series [__]
Purchaser at least three Business Days prior to the Series [__] Closing Date). At or prior to the time that it purchases a Series [__] Note (including by succession or pursuant to an assignment permitted hereunder) and, so long as it remains
legally eligible to do so, from time to time thereafter, each Series [__] Purchaser will duly complete and deliver to the Company (i) in the case of a Series [__] Purchaser that is not a United States person for U.S. federal income tax
purposes, two copies of any U.S. Internal Revenue Service (“IRS”) Forms W-8 or W-8BEN E as applicable (or other category of Form W-8 prescribed by law and acceptable to the Company in its discretion) along with any supporting statements or additional information, in each case, that are reasonably necessary to establish the extent to which the
Series [_] Purchaser is entitled to a reduction in the rate of any U.S. withholding Tax imposed with respect to payments on the Series [_] Notes and any successor or additional form required by the IRS or reasonably requested by the Company in
order to evidence such Purchaser’s entitlement to such reduction or (ii) in the case of a Series [__] Purchaser that is a United States person for U.S. federal income tax purposes, an IRS Form
W-9 or successor form establishing that the Series [__] Purchaser is not subject to any U.S. withholding tax (including backup withholding tax) with respect to payments on the Series [__] Notes and
(iii) any other forms or information reasonably requested by the Company necessary for the Company to comply with its obligations under FATCA and to determine that such Series [_] Purchaser has complied with its obligations under FATCA or to
determine the amount (if any) to deduct and withhold from any payment to such Purchaser. For the avoidance of doubt, if the Company (or any applicable withholding agent) is required by applicable law to deduct or withhold any Taxes (including under
FATCA) from or with respect to a Series [_] Note or payments under such a Note, then (a) the Company (or applicable withholding agent) may make such withholding or deduction and remit such Taxes to the applicable Governmental Authority,
(b) the Company shall not be obligated to indemnify the holder or beneficial owner of such Note or pay any additional amounts with respect to such withholding or deduction and (c) such withheld amounts shall be treated as paid with respect
to such Note for all purposes hereunder. 
 C. Conditions of Series Closing. The obligation of each
Series [__] Purchaser to purchase and pay for the Series [__] Notes to be purchased by such purchaser hereunder on the Series [__] Closing Date is subject to the satisfaction, on or before such Series [__] Closing Date, of the
conditions set forth below. 
 [applicable conditions precedent to be inserted] 

  
 Schedule 3 – 2 

 D. Prepayments. The Series [__] Notes shall be subject to prepayment only
(a) pursuant to the required prepayments, if any, specified in clause [(x)] below; and (b) pursuant to the optional prepayments permitted by Section 7.2 of the Agreement. 

(x) Required Prepayments; Maturity 

[to be determined] 

(y) Optional and Contingent Prepayments. As provided in Section 7.2 of the Agreement. 

E. Additional Provisions. [Add additional Terms and Conditions] 

F. Representations and Warranties of the Transaction Obligors. The Company represents and warrants to the Purchasers that each of the
representations and warranties contained in Section 5 of the Agreement is true and correct as of the date hereof (i) except that (1) all references to “Initial Purchaser” therein shall be deemed to refer to the Purchasers
hereunder, (2) all references to “this Agreement” shall be deemed to refer to the Agreement as supplemented by this Supplement, (3) all references to “Initial Notes” therein shall be deemed to include the Series [_]
Notes and (4) [other modifications/deletions of representations and warranties], and (ii) except for changes to such representations and warranties or the Schedules referred to therein, which changes are set forth in the attached
Schedule [__]. 
 G. Representations and Warranties of the Purchasers. Each Series [__] Purchaser represents and warrants that the
representations and warranties set forth in Section 6 of the Agreement are true and correct on the date hereof with respect to the purchase of the Series [__] Notes by such Series [__] Purchaser. [include modifications/deletions of
representations and warranties] 
 H. Series Notes Issued under and Pursuant to Agreement. Except as
specifically provided above, the Series [__] Notes shall be deemed to be issued under, to be subject to and to have the benefit of all of the terms and provisions of the Agreement as the same may from time to time be amended and supplemented in
the manner provided therein. 
 I. Priority of Security. Each Series [__] Note shall be deemed to be a “Note” under
the Agreement and shall rank pari passu and be secured equally and ratably by the Collateral without discrimination or preference with all other Notes as if all of the Notes had been issued simultaneously. 

J. Applicability of Agreement. Except as otherwise expressly provided herein (and expressly permitted by the Agreement), all of the
provisions of the Agreement are incorporated by reference herein and shall apply to the Series [_] Notes as if expressly set forth in this Supplement except that all references to “Notes” therein shall be deemed to include the Series [_]
Notes. 

  
 Schedule 3 – 3 

 The execution hereof by the Series [__] Purchasers shall constitute a contract among
the Company and the Series [__] Purchasers for the uses and purposes hereinabove set forth. By their acceptance hereof, each of the Series [__] Purchasers shall also be deemed to have accepted and agreed to the terms and provisions of the
Agreement, as in effect on the date hereof. 
  

			
	BATH COUNTY ENERGY, LLC

 
			
		
	By:	 	 
		 	Its:

 Accepted as of 
  

 
  

			
	[ADD PURCHASER SIGNATURE BLOCKS]

 
			
		
	By:	 	 
		 	Its:

  
 Schedule 3 – 4EX-10.2

 Exhibit 10.2 

REV RENEWABLES INC. 

2022 LONG TERM INCENTIVE PLAN 

1. Purpose. The purpose of the REV Renewables Inc. 2022 Long Term Incentive Plan (the “Plan”) is to provide a
means through which (a) REV Renewables Inc., a Delaware corporation (the “Company”), and the Affiliates may attract, retain and motivate qualified persons as employees, directors, consultants, and other individual
service providers, thereby enhancing the profitable growth of the Company and the Affiliates and (b) persons upon whom the responsibilities of the successful administration and management of the Company and the Affiliates rest, and whose
present and potential contributions to the Company and the Affiliates are of importance, can acquire and maintain stock ownership or awards, the value of which is tied to the performance of the Company, thereby strengthening their concern for the
Company and the Affiliates. Accordingly, the Plan provides for the grant of Options, SARs, Restricted Stock, Restricted Stock Units, Stock Awards, Dividend Equivalents, Other Stock-Based Awards, Cash Awards, Substitute Awards, or any combination of
the foregoing, as determined by the Committee in its sole discretion. 
 2. Definitions. For purposes of the Plan, the following
terms shall be defined as set forth below: 
 (a) “Affiliate” means, with respect to any person or entity, any
corporation, partnership, limited liability company, limited liability partnership, association, trust or other organization that, directly or indirectly, controls, is controlled by, or is under common control with, such person or entity. For
purposes of the preceding sentence, “control” (including, with correlative meanings, the terms “controlled by” and “under common control with”), as used with respect to any entity or organization, shall mean the
possession, directly or indirectly, of the power (i) to vote more than 50% of the securities having ordinary voting power for the election of directors of the controlled entity or organization or (ii) to direct or cause the direction of
the management and policies of the controlled entity or organization, whether through the ownership of voting securities, by contract, or otherwise. 

(b) “ASC Topic 718” means the Financial Accounting Standards Board Accounting Standards Codification Topic 718,
Compensation – Stock Compensation, as amended or any successor accounting standard. 
 (c) “Award” means
any Option, SAR, Restricted Stock, Restricted Stock Unit, Stock Award, Dividend Equivalent, Other Stock-Based Award, Cash Award, or Substitute Award, together with any other right or interest, granted under the Plan. 

(d) “Award Agreement” means any written instrument (including any employment, severance or change in control
agreement) that sets forth the terms, conditions, restrictions and/or limitations applicable to an Award, in addition to those set forth under the Plan. 

(e) “Board” means the Board of Directors of the Company. 

(f) “Cash Award” means an Award denominated in cash granted under Section 6(i). 

 (g) “Change in Control” means, except as otherwise provided in an
Award Agreement, the occurrence of any of the following events after the Effective Date: 
 (i) The acquisition by any individual, entity
or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 50% or more of either
(x) the then-outstanding shares of Stock (the “Outstanding Stock”) or (y) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors
(the “Outstanding Company Voting Securities”); provided, however, that for purposes of this clause (i), the following acquisitions shall not constitute a Change in Control: (A) any acquisition directly from
the Company, (B) any acquisition by the Company or its subsidiaries, (C) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any entity controlled by the Company or (D) any
acquisition by any entity pursuant to a transaction that complies with clauses (A), (B) and (C) of clause (iii) below; 
 (ii)
The individuals constituting the Board on the Effective Date (the “Incumbent Directors”) cease for any reason (other than death or disability) to constitute at least majority of the Board; provided, however,
that any individual becoming a director subsequent to the Effective Date whose election, or nomination for election, by the Company’s stockholders was approved by a vote of at least two-thirds of the
Incumbent Directors (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without objection to such nomination) will be considered as though such individual were an
Incumbent Director, but excluding, for purposes of this proviso, any such individual whose initial assumption of office occurs as a result of an actual or threatened proxy contest with respect to election or removal of directors or other actual or
threatened solicitation of proxies or consents by or on behalf of a “person” (as used in Section 13(d) of the Exchange Act), in each case, other than the Board, which individual, for the avoidance of doubt, shall not be deemed to be
an Incumbent Director for purposes of this definition, regardless of whether such individual was approved by a vote of at least two-thirds of the Incumbent Directors; 

(iii) Consummation of a reorganization, merger or consolidation or sale or other disposition of all or substantially all of the assets of the
Company or an acquisition of assets of another entity (a “Business Combination”), in each case, unless, following such Business Combination, (A) the Outstanding Stock and Outstanding Company Voting Securities immediately
prior to such Business Combination represent or are converted into or exchanged for securities which represent or are convertible into more than 50% of, respectively, the then-outstanding shares of common stock or common equity interests and the
combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors or other governing body, as the case may be, of the entity resulting from such Business Combination (including, without
limitation, an entity which as a result of such transaction owns the Company, or all or substantially all of the Company’s assets either directly or through one or more subsidiaries), (B) no individual, entity or group (within the meaning of
Section 13(d)(3) or 14(d)(2) of the Exchange Act), excluding the Company, its subsidiaries and any employee benefit plan (or related trust) sponsored or maintained by the Company or the entity resulting from such Business Combination (or any
entity controlled by either the Company or the entity resulting from such Business Combination), beneficially owns, directly or indirectly, 50% or more of, respectively, the then-outstanding shares of common stock or common equity interests of the
entity resulting from 

 
such Business Combination or the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors or other governing body of such entity
except to the extent that such ownership results solely from direct or indirect ownership of the Company that existed prior to the Business Combination, and (C) at least a majority of the members of the board of directors or similar governing
body of the entity resulting from such Business Combination were Incumbent Directors at the time of the execution of the initial agreement, or of the action of the Board, providing for such Business Combination; or 

(iv) Approval by the stockholders of the Company of a complete liquidation or dissolution of the Company. 

Notwithstanding any provision of this Section 2(g), for purposes of an Award that provides for a deferral of compensation under the
Nonqualified Deferred Compensation Rules, to the extent the impact of a Change in Control on such Award would subject a Participant to additional taxes under the Nonqualified Deferred Compensation Rules, a Change in Control described in subsection
(i), (ii), (iii) or (iv) above with respect to such Award will mean both a Change in Control and a “change in the ownership of a corporation,” “change in the effective control of a corporation,” or a “change in the
ownership of a substantial portion of a corporation’s assets” within the meaning of the Nonqualified Deferred Compensation Rules as applied to the Company. 

(h) “Change in Control Price” means the amount determined in the following clause (i), (ii), (iii), (iv) or (v),
whichever the Committee determines is applicable, as follows: (i) the price per share offered to holders of Stock in any merger or consolidation, (ii) the per share Fair Market Value of the Stock immediately before the Change in Control or
other event without regard to assets sold in the Change in Control or other event and assuming the Company has received the consideration paid for the assets in the case of a sale of the assets, (iii) the amount distributed per share of Stock
in a dissolution transaction, (iv) the price per share offered to holders of Stock in any tender offer or exchange offer whereby a Change in Control or other event takes place, or (v) if such Change in Control or other event occurs other
than pursuant to a transaction described in clauses (i), (ii), (iii), or (iv) of this Section 2(h), the value per share of the Stock that may otherwise be obtained with respect to such Awards or to which such Awards
track, as determined by the Committee as of the date determined by the Committee to be the date of cancellation and surrender of such Awards. In the event that the consideration offered to stockholders of the Company in any transaction described in
this Section 2(h) or in Section 8(e) consists of anything other than cash, the Committee shall determine the fair cash equivalent of the portion of the consideration offered which is other than
cash and such determination shall be binding on all affected Participants to the extent applicable to Awards held by such Participants. 

(i) “Code” means the Internal Revenue Code of 1986, as amended from time to time, including the guidance and
regulations promulgated thereunder and successor provisions, guidance and regulations thereto. 
 (j) “Committee”
means a committee of two or more directors designated by the Board to administer the Plan; provided, however, that, unless otherwise determined by the Board, the Committee shall consist solely of two or more Qualified Members. 

 (k) “Dividend Equivalent” means a right, granted to an Eligible
Person under Section 6(g), to receive cash, Stock, other Awards or other property equal in value to dividends paid with respect to a specified number of shares of Stock, or other periodic payments. 

(l) “Effective Date”
means                , 2022. 
 (m) “Eligible
Person” means any individual who, as of the date of grant of an Award, is an officer or employee of the Company or of any Affiliate, and any other person who provides services to the Company or any Affiliate, including directors of the
Company; provided, however, that, any such individual must be an “employee” of the Company or any of its parents or subsidiaries within the meaning of General Instruction A.1(a) to Form
S-8 if such individual is granted an Award that may be settled in Stock. An employee on leave of absence may be an Eligible Person. 

(n) “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, including the guidance,
rules and regulations promulgated thereunder and successor provisions, guidance, rules and regulations thereto. 
 (o) “Fair
Market Value” of a share of Stock means, as of any specified date, (i) if the Stock is listed on a national securities exchange, the closing sales price of the Stock, as reported on the stock exchange composite tape on that date
(or if no sales occur on such date, on the last preceding date on which such sales of the Stock are so reported); (ii) if the Stock is not traded on a national securities exchange but is traded over the counter on such date, the average between the
reported high and low bid and asked prices of Stock on the most recent date on which Stock was publicly traded on or preceding the specified date; or (iii) in the event Stock is not publicly traded at the time a determination of its value is
required to be made under the Plan, the amount determined by the Committee in its discretion in such manner as it deems appropriate, taking into account all factors the Committee deems appropriate, including the Nonqualified Deferred Compensation
Rules. Notwithstanding this definition of Fair Market Value, with respect to one or more Award types, or for any other purpose for which the Committee must determine the Fair Market Value under the Plan, the Committee may elect to choose a different
measurement date or methodology for determining Fair Market Value so long as the determination is consistent with the Nonqualified Deferred Compensation Rules and all other applicable laws and regulations. 

(p) “ISO” means an Option intended to be and designated as an “incentive stock option” within the meaning of
Section 422 of the Code. 
 (q) “Nonqualified Deferred Compensation Rules” means the limitations and
requirements of Section 409A of the Code, as amended from time to time, including the guidance and regulations promulgated thereunder and successor provisions, guidance and regulations thereto. 

(r) “Nonstatutory Option” means an Option that is not an ISO. 

(s) “Option” means a right, granted to an Eligible Person under Section 6(b), to purchase
Stock at a specified price during specified time periods, which may either be an ISO or a Nonstatutory Option. 

 (t) “Other Stock-Based Award” means an Award granted to an Eligible
Person under Section 6(h). 
 (u) “Participant” means a person who has been granted an
Award under the Plan that remains outstanding, including a person who is no longer an Eligible Person. 
 (v) “Qualified
Member” means a member of the Board who is (i) a “non-employee director” within the meaning of Rule 16b-3(b)(3), and (ii)
“independent” under the listing standards or rules of the securities exchange upon which the Stock is traded, but only to the extent such independence is required in order to take the action at issue pursuant to such standards or rules.

 (w) “Restricted Stock” means Stock granted to an Eligible Person under Section 6(d)
that is subject to certain restrictions and to a risk of forfeiture. 
 (x) “Restricted Stock Unit” means a right,
granted to an Eligible Person under Section 6(e), to receive Stock, cash or a combination thereof at the end of a specified period (which may or may not be coterminous with the vesting schedule of the Award). 

(y) “Rule 16b-3” means Rule 16b-3,
promulgated by the SEC under Section 16 of the Exchange Act. 
 (z) “SAR” means a stock appreciation right
granted to an Eligible Person under Section 6(c). 
 (aa) “SEC” means the Securities and
Exchange Commission. 
 (bb) “Securities Act” means the Securities Act of 1933, as amended from time to time,
including the guidance, rules and regulations promulgated thereunder and successor provisions, guidance, rules and regulations thereto. 

(cc) “Stock” means the Company’s common stock, par value $0.01 per share, and such other securities as may be
substituted (or re-substituted) for Stock pursuant to Section 8. 
 (dd)
“Stock Award” means unrestricted shares of Stock granted to an Eligible Person under Section 6(f). 

(ee) “Substitute Award” means an Award granted under Section 6(j). 

3. Administration. 
 (a)
Authority of the Committee. The Plan shall be administered by the Committee except to the extent the Board elects to administer the Plan, in which case references herein to the “Committee” shall be deemed to include references to
the “Board.” Subject to the express provisions of the Plan, Rule 16b-3 and other applicable laws, the Committee shall have the authority, in its sole and absolute discretion, to: 

(i) designate Eligible Persons as Participants; 

 (ii) determine the type or types of Awards to be granted to an Eligible Person; 

(iii) determine the number of shares of Stock or amount of cash to be covered by Awards; 

(iv) determine the terms and conditions of any Award, including whether, to what extent and under what circumstances Awards may be vested,
settled, exercised, cancelled or forfeited (including conditions based on continued employment or service requirements or the achievement of one or more performance goals); 

(v) modify, waive or adjust any term or condition of an Award that has been granted, which may include the acceleration of vesting, waiver of
forfeiture restrictions, modification of the form of settlement of the Award (for example, from cash to Stock or vice versa), early termination of a performance period, or modification of any other condition or limitation regarding an Award; 

(vi) determine the treatment of an Award upon a termination of employment or other service relationship; 

(vii) impose a holding period with respect to an Award or the shares of Stock received in connection with an Award; 

(viii) interpret and administer the Plan and any Award Agreement; 

(ix) correct any defect, supply any omission or reconcile any inconsistency in the Plan, in any Award, or in any Award Agreement; and 

(x) make any other determination and take any other action that the Committee deems necessary or desirable for the administration of the
Plan. 
 The express grant of any specific power to the Committee, and the taking of any action by the Committee, shall not be construed as limiting any
power or authority of the Committee. Any action of the Committee shall be final, conclusive and binding on all persons, including the Company, Affiliates, stockholders, Participants, beneficiaries, and permitted transferees under
Section 7(a) or other persons claiming rights from or through a Participant. The Committee’s determinations need not be uniform with respect to Participants, and need not apply consistently across Awards. 

(b) Exercise of Committee Authority. At any time that a member of the Committee is not a Qualified Member, any action of the Committee
relating to an Award granted or to be granted to an Eligible Person who is then subject to Section 16 of the Exchange Act in respect of the Company where such action is not taken by the full Board may be taken either (i) by a subcommittee,
designated by the Committee, composed solely of two or more Qualified Members, or (ii) by the Committee but with each such member who is not a Qualified Member abstaining or recusing himself or herself from such action; provided,
however, that upon such abstention or recusal, the Committee remains composed solely of two or more Qualified Members. Such action, authorized by such a subcommittee or by the Committee upon the abstention or recusal of such non-Qualified Member(s), shall be the action of the Committee for purposes of the Plan. For the avoidance of doubt, the full Board may take any action relating to an Award granted or to be granted to an Eligible
Person who is then subject to Section 16 of the Exchange Act in respect of the Company. 

 (c) Delegation of Authority. The Committee may delegate any or all of its powers and
duties under the Plan to a subcommittee of directors or to any officer of the Company, including the power to perform administrative functions and grant Awards; provided, that such delegation does not (i) violate state or corporate law,
or (ii) result in the loss of an exemption under Rule 16b-3(d)(1) for Awards granted to Participants subject to Section 16 of the Exchange Act in respect of the Company. Upon any such delegation, all
references in the Plan to the “Committee,” other than in Section 8, shall be deemed to include any subcommittee or officer of the Company to whom such powers have been delegated by the Committee. Any such
delegation shall not limit the right of such subcommittee members or such an officer to receive Awards; provided, however, that such subcommittee members and any such officer may not grant Awards to himself or herself, a member of the
Board, or any executive officer of the Company or an Affiliate, or take any action with respect to any Award previously granted to himself or herself, a member of the Board, or any executive officer of the Company or an Affiliate. The Committee may
also appoint agents who are not executive officers of the Company or members of the Board to assist in administering the Plan, provided, however, that such individuals may not be delegated the authority to grant or modify any Awards
that will, or may, be settled in Stock. 
 (d) Limitation of Liability. The Committee and each member thereof shall be entitled to,
in good faith, rely or act upon any report or other information furnished to him or her by any officer or employee of the Company or any Affiliate, the Company’s legal counsel, independent auditors, consultants or any other agents assisting in
the administration of the Plan. Members of the Committee and any officer or employee of the Company or any Affiliate acting at the direction or on behalf of the Committee shall not be personally liable for any action or determination taken or made
in good faith with respect to the Plan, and shall, to the fullest extent permitted by law, be indemnified and held harmless by the Company with respect to any such action or determination. 

(e) Participants in Non-U.S. Jurisdictions. Notwithstanding any provision of the Plan to the
contrary, to comply with applicable laws in countries other than the United States in which the Company or any Affiliate operates or has employees, directors or other service providers from time to time, or to ensure that the Company complies with
any applicable requirements of foreign securities exchanges, the Committee, in its sole discretion, shall have the power and authority to: (i) determine which of the Affiliates shall be covered by the Plan; (ii) determine which Eligible
Persons outside the United States are eligible to participate in the Plan; (iii) modify the terms and conditions of any Award granted to Eligible Persons outside the United States to comply with applicable foreign laws or listing requirements
of any foreign exchange; (iv) establish sub-plans and modify exercise procedures and other terms and procedures, to the extent such actions may be necessary or advisable (any such sub-plans and/or modifications shall be attached to the Plan as appendices), provided, however, that no such sub-plans and/or modifications shall increase the
share limitations contained in Section 4(a); and (v) take any action, before or after an Award is granted, that it deems advisable to comply with any applicable governmental regulatory exemptions or approval or listing
requirements of any such foreign securities exchange. For purposes of the Plan, all references to foreign laws, rules, regulations or taxes shall be references to the laws, rules, regulations and taxes of any applicable jurisdiction other than the
United States or a political subdivision thereof. 

 4. Stock Subject to the Plan. 

(a) Number of Shares Available for Delivery. Subject to adjustment in a manner consistent with Section 8,
shares of Stock are reserved and available for delivery with respect to Awards, and such total shall be available for the issuance of shares upon the exercise of ISOs. 

(b) Availability of Shares Not Delivered under Awards. If all or any portion of an Award expires or is cancelled, forfeited, exchanged,
settled in cash or otherwise terminated, the shares of Stock subject to such Award (including (i) shares forfeited with respect to Restricted Stock, and (ii) the number of shares withheld or surrendered to the Company in payment of any
exercise or purchase price of an Award or taxes relating to Awards) shall not be considered “delivered shares” under the Plan, and shall be available for delivery with respect to Awards. If an Award may be settled only in cash, such Award
need not be counted against any share limit under this Section 4. 
 (c) Shares Available Following Certain
Transactions. Substitute Awards granted in accordance with applicable stock exchange requirements and in substitution or exchange for awards previously granted by a company acquired by the Company or any subsidiary or with which the Company or
any subsidiary combines shall not reduce the shares authorized for issuance under the Plan or the limitations on grants to non-employee members of the Board under Section 5(b), nor
shall shares subject to such Substitute Awards be added to the shares available for issuance under the Plan as provided above (whether or not such Substitute Awards are later cancelled, forfeited or otherwise terminated). 

(d) Stock Offered. The shares of Stock to be delivered under the Plan shall be made available from (i) authorized but unissued
shares of Stock, (ii) Stock held in the treasury of the Company, or (iii) previously issued shares of Stock reacquired by the Company, including shares purchased on the open market. 

5. Eligibility; Award Limitations for Non-Employee Members of the Board. 

(a) Awards may be granted under the Plan only to Eligible Persons. 

(b) In each calendar year during any part of which the Plan is in effect, a non-employee member of the
Board may not be granted Awards for such individual’s service on the Board having a value (determined, if applicable, pursuant to ASC Topic 718) on the date of grant in excess of $750,000; provided, that for any calendar year in which a non-employee member of the Board (i) first commences service on the Board, (ii) serves on a special committee of the Board, or (iii) serves as lead director or chairman of the Board, additional Awards
may be granted to such non-employee member of the Board in excess of such limit; provided, further, that the limit set forth in this Section 5(b) shall be applied
without regard to (A) cash fees paid to a non-employee member of the Board during such calendar year (or grants of Awards, if any, made to a non-employee member of
the Board in lieu of all or any portion of such cash fees) or (B) grants of Awards, if any, made to a non-employee member of the Board during any period in which such individual was an employee of the
Company or any Affiliate or was otherwise providing services to the Company or to any Affiliate other than in the capacity as a director of the Company. 

 6. Specific Terms of Awards. 

(a) General. Awards may be granted on the terms and conditions set forth in this Section 6. Awards granted
under the Plan may, in the discretion of the Committee, be granted either alone, in addition to, or in tandem with any other Award. In addition, the Committee may impose on any Award or the exercise thereof, at the date of grant or thereafter
(subject to Section 10), such additional terms and conditions, not inconsistent with the provisions of the Plan, as the Committee shall determine, including subjecting such awards to service- or performance-based vesting
conditions. Without limiting the scope of the preceding sentence, with respect to any performance-based conditions, (i) the Committee may use such business criteria and other measures of performance as it may deem appropriate in establishing
any performance goals applicable to an Award, and (ii) any such performance goals may relate to the performance of the Participant, the Company (on a consolidated basis), or to specified subsidiaries, business or geographical units or operating
areas of the Company, (iii) the performance period or periods over which performance goals will be measured shall be established by the Committee, and (iv) any such performance goals and performance periods may differ among Awards granted
to any one Participant or to different Participants. Except as otherwise provided in an Award Agreement, the Committee may exercise its discretion to reduce or increase the amounts payable under any Award. 

(b) Options. The Committee is authorized to grant Options, which may be designated as either ISOs or Nonstatutory Options, to Eligible
Persons on the following terms and conditions: 
 (i) Exercise Price. Each Award Agreement evidencing an Option shall state the
exercise price per share of Stock (the “Exercise Price”) established by the Committee; provided, however, that except as provided in Section 6(j) or in
Section 8, the Exercise Price of an Option shall not be less than the greater of (A) the par value per share of the Stock or (B) 100% of the Fair Market Value per share of the Stock as of the date of grant of the
Option (or in the case of an ISO granted to an individual who owns stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or its parent or any of its subsidiaries, 110% of the Fair Market Value per
share of the Stock on the date of grant). 
 (ii) Time and Method of Exercise; Other Terms. The Committee shall determine the
methods by which the Exercise Price may be paid or deemed to be paid, the form of such payment, including cash or cash equivalents, Stock (including previously owned shares or through a cashless exercise, i.e., “net settlement”, a
broker-assisted exercise, or other reduction of the amount of shares otherwise issuable pursuant to the Option), other Awards or awards granted under other plans of the Company or any Affiliate, other property, or any other legal consideration the
Committee deems appropriate (including notes or other contractual obligations of Participants to make payment on a deferred basis), the methods by or forms in which Stock will be delivered or deemed to be delivered to Participants, including the
delivery of Restricted Stock subject to Section 6(d), and any other terms and conditions of any Option. In the case of an exercise whereby the Exercise Price is paid with Stock, such Stock shall be valued based on the
Stock’s Fair Market 

 
Value as of the date of exercise. No Option may be exercisable for a period of more than ten years following the date of grant of the Option (or in the case of an ISO granted to an individual who
owns stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or its parent or any of its subsidiaries, for a period of more than five years following the date of grant of the ISO). 

(iii) ISOs. The terms of any ISO granted under the Plan shall comply in all respects with the provisions of Section 422 of the
Code. ISOs may only be granted to Eligible Persons who are employees of the Company or employees of a parent or any subsidiary corporation of the Company. Except as otherwise provided in Section 8, no term of the Plan
relating to ISOs (including any SAR in tandem therewith) shall be interpreted, amended or altered, nor shall any discretion or authority granted under the Plan be exercised, so as to disqualify either the Plan or any ISO under Section 422 of
the Code, unless notice has been provided to the Participant that such change will result in such disqualification. ISOs shall not be granted more than ten years after the earlier of the adoption of the Plan or the approval of the Plan by the
Company’s stockholders. Notwithstanding the foregoing, to the extent that the aggregate Fair Market Value of shares of Stock subject to an ISO and the aggregate Fair Market Value of shares of stock of any parent or subsidiary corporation
(within the meaning of Sections 424(e) and (f) of the Code) subject to any other incentive stock options of the Company or a parent or subsidiary corporation (within the meaning of Sections 424(e) and (f) of the Code) that are exercisable
for the first time by a Participant during any calendar year exceeds $100,000, or such other amount as may be prescribed under Section 422 of the Code, such excess shall be treated as Nonstatutory Options in accordance with the Code. As used in
the previous sentence, Fair Market Value shall be determined as of the date the ISO is granted. If a Participant shall make any disposition of shares of Stock issued pursuant to an ISO under the circumstances described in Section 421(b) of the
Code (relating to disqualifying dispositions), the Participant shall notify the Company of such disposition within the time provided to do so in the applicable award agreement. 

(c) SARs. The Committee is authorized to grant SARs to Eligible Persons on the following terms and conditions: 

(i) Right to Payment. An SAR is a right to receive, upon exercise thereof, the excess of (A) the Fair Market Value of one share
of Stock on the date of exercise over (B) the grant price of the SAR as determined by the Committee. 
 (ii) Grant Price. Each
Award Agreement evidencing an SAR shall state the grant price per share of Stock established by the Committee; provided, however, that except as provided in Section 6(j) or in
Section 8, the grant price per share of Stock subject to an SAR shall not be less than the greater of (A) the par value per share of the Stock or (B) 100% of the Fair Market Value per share of the Stock as of the date
of grant of the SAR. 
 (iii) Method of Exercise and Settlement; Other Terms. The Committee shall determine the form of
consideration payable upon settlement, the method by or forms in which Stock (if any) will be delivered or deemed to be delivered to Participants, and any other terms and conditions of any SAR. SARs may be either free-standing or granted in tandem
with other Awards. No SAR may be exercisable for a period of more than ten years following the date of grant of the SAR. 

 (iv) Rights Related to Options. An SAR granted in connection with an Option shall
entitle a Participant, upon exercise, to surrender that Option or any portion thereof, to the extent unexercised, and to receive payment of an amount determined by multiplying (A) the difference obtained by subtracting the Exercise Price with
respect to a share of Stock specified in the related Option from the Fair Market Value of a share of Stock on the date of exercise of the SAR, by (B) the number of shares as to which that SAR has been exercised. The Option shall then cease to
be exercisable to the extent surrendered. SARs granted in connection with an Option shall be subject to the terms and conditions of the Award Agreement governing the Option, which shall provide that the SAR is exercisable only at such time or times
and only to the extent that the related Option is exercisable and shall not be transferable except to the extent that the related Option is transferrable. 

(d) Restricted Stock. The Committee is authorized to grant Restricted Stock to Eligible Persons on the following terms and conditions:

 (i) Restrictions. Restricted Stock shall be subject to such restrictions on transferability, risk of forfeiture and other
restrictions, if any, as the Committee may impose. Except as provided in Section 7(a)(iii) and Section 7(a)(iv), during the restricted period applicable to the Restricted Stock, the Restricted
Stock may not be sold, transferred, pledged, hedged, hypothecated, margined or otherwise encumbered by the Participant. 
 (ii)
Dividends and Splits. As a condition to the grant of an Award of Restricted Stock, the Committee may allow a Participant to elect, or may require, that any cash dividends paid on a share of Restricted Stock be automatically reinvested in
additional shares of Restricted Stock, applied to the purchase of additional Awards or deferred without interest to the date of vesting of the associated Award of Restricted Stock. Unless otherwise determined by the Committee and specified in the
applicable Award Agreement, Stock distributed in connection with a Stock split or Stock dividend, and other property (other than cash) distributed as a dividend, shall be subject to restrictions and a risk of forfeiture to the same extent as the
Restricted Stock with respect to which such Stock or other property has been distributed. 
 (e) Restricted Stock Units. The
Committee is authorized to grant Restricted Stock Units to Eligible Persons on the following terms and conditions: 
 (i) Award and
Restrictions. Restricted Stock Units shall be subject to such restrictions (which may include a risk of forfeiture) as the Committee may impose. 

(ii) Settlement. Settlement of vested Restricted Stock Units shall occur upon vesting or upon expiration of the deferral period
specified for such Restricted Stock Units by the Committee (or, if permitted by the Committee, as elected by the Participant). Restricted Stock Units shall be settled by delivery of (A) a number of shares of Stock equal to the number of
Restricted Stock Units for which settlement is due, or (B) cash in an amount equal to the Fair Market Value of the specified number of shares of Stock equal to the number of Restricted Stock Units for which settlement is due, or a combination
thereof, as determined by the Committee at the date of grant or thereafter. 

 (f) Stock Awards. The Committee is authorized to grant Stock Awards to Eligible
Persons as a bonus, as additional compensation, or in lieu of cash compensation any such Eligible Person is otherwise entitled to receive, in such amounts and subject to such other terms as the Committee in its discretion determines to be
appropriate. 
 (g) Dividend Equivalents. The Committee is authorized to grant Dividend Equivalents to Eligible Persons, entitling
any such Eligible Person to receive cash, Stock, other Awards, or other property equal in value to dividends or other distributions paid with respect to a specified number of shares of Stock. Dividend Equivalents may be awarded on a free-standing
basis or in connection with another Award (other than an Award of Restricted Stock or a Stock Award). The Committee may provide that Dividend Equivalents shall be paid or distributed when accrued or at a later specified date and, if distributed at a
later date, may be deemed to have been reinvested in additional Stock, Awards, or other investment vehicles or accrued in a bookkeeping account without interest, and subject to such restrictions on transferability and risks of forfeiture, as the
Committee may specify. With respect to Dividend Equivalents granted in connection with another Award, absent a contrary provision in the Award Agreement, such Dividend Equivalents shall be subject to the same restrictions and risk of forfeiture as
the Award with respect to which the dividends accrue and shall not be paid unless and until such Award has vested and been earned. 
 (h)
Other Stock-Based Awards. The Committee is authorized, subject to limitations under applicable law, to grant to Eligible Persons such other Awards that may be denominated or payable in, valued in whole or in part by reference to, or otherwise
based on, or related to, Stock, as deemed by the Committee to be consistent with the purposes of the Plan, including convertible or exchangeable debt securities, other rights convertible or exchangeable into Stock, purchase rights for Stock, Awards
with value and payment contingent upon performance of the Company or any other factors designated by the Committee, and Awards valued by reference to the book value of Stock or the value of securities of, or the performance of, specified Affiliates.
The Committee shall determine the terms and conditions of such Other Stock-Based Awards. Stock delivered pursuant to an Other-Stock Based Award in the nature of a purchase right granted under this Section 6(h) shall be
purchased for such consideration, paid for at such times, by such methods, and in such forms, including cash, Stock, other Awards, or other property, as the Committee shall determine. 

(i) Cash Awards. The Committee is authorized to grant Cash Awards, on a free-standing basis or as an element of, a supplement to, or in
lieu of any other Award under the Plan to Eligible Persons in such amounts and subject to such other terms as the Committee in its discretion determines to be appropriate. 

(j) Substitute Awards; No Repricing. Awards may be granted in substitution or exchange for any other Award granted under the Plan or
under another plan of the Company or an Affiliate or any other right of an Eligible Person to receive payment from the Company or an Affiliate. Awards may also be granted under the Plan in substitution for awards held by individuals who become
Eligible Persons as a result of a merger, consolidation or acquisition of another entity or the assets of another entity by or with the Company or an Affiliate. Such Substitute Awards referred to in the immediately preceding sentence that are
Options or SARs may have an exercise price that is less than the Fair Market Value of a share of Stock on the date of the substitution if such substitution complies with the Nonqualified Deferred Compensation Rules, Section 424 of

 
the Code and the Guidance and regulations promulgated thereunder, if applicable, and other applicable laws and exchange rules. Except as provided in this Section 6(j) or
in Section 8, without the approval of the stockholders of the Company, the terms of outstanding Awards may not be amended to (i) reduce the Exercise Price or grant price of an outstanding Option or SAR, (ii) grant
a new Option, SAR in substitution for, or upon the cancellation of, any previously granted Option or SAR that has the effect of reducing the Exercise Price or grant price thereof, (iii) exchange any Option or SAR for Stock, cash or other
consideration when the Exercise Price or grant price per share of Stock under such Option or SAR exceeds the Fair Market Value of a share of Stock or (iv) take any other action that would be considered a “repricing” of an Option or
SAR under the applicable listing standards of the national securities exchange on which the Stock is listed (if any). 
 7. Certain
Provisions Applicable to Awards. 
 (a) Limit on Transfer of Awards. 

(i) Except as provided in Sections 7(a)(iii) and (iv), each Option and SAR shall be exercisable only by the Participant during
the Participant’s lifetime, or by the person to whom the Participant’s rights shall pass by will or the laws of descent and distribution. Notwithstanding anything to the contrary in this Section 7(a), an ISO shall
not be transferable other than by will or the laws of descent and distribution. 
 (ii) Except as provided in Sections 7(a)(i),
(iii) and (iv), no Award, other than a Stock Award, and no right under any such Award, may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by a Participant and any such purported assignment,
alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or any Affiliate. 

(iii) To the extent specifically provided by the Committee and permitted pursuant to Form S-8 and the
instructions thereto, an Award may be transferred by a Participant on such terms and conditions as the Committee may from time to time establish; provided, however, that no Award (other than a Stock Award) may be transferred to a
third-party financial institution for value. 
 (iv) An Award may be transferred pursuant to a domestic relations order entered or approved
by a court of competent jurisdiction upon delivery to the Company of a written request for such transfer and a certified copy of such order. 

(b) Form and Timing of Payment under Awards; Deferrals. Subject to the terms of the Plan and any applicable Award Agreement, payments
to be made by the Company or any Affiliates upon the exercise or settlement of an Award may be made in such forms as the Committee shall determine in its discretion, including cash, Stock, other Awards or other property, and may be made in a single
payment or transfer, in installments, or on a deferred basis (which may be required by the Committee or permitted at the election of the Participant on terms and conditions established by the Committee); provided, however, that any
such deferred or installment payments will be set forth in the Award Agreement. Payments may include, without limitation, provisions for the payment or crediting of reasonable interest on installment or deferred payments or the grant or crediting of
Dividend Equivalents or other amounts in respect of installment or deferred payments denominated in Stock. 

 (c) Evidencing Stock. The Stock or other securities of the Company delivered pursuant
to an Award may be evidenced in any manner deemed appropriate by the Committee in its sole discretion, including in the form of a certificate issued in the name of the Participant or by book entry, electronic or otherwise, and shall be subject to
such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan or the rules, regulations, and other requirements of the SEC, any stock exchange upon which such Stock or other securities are then listed, and any
applicable federal, state or other laws, and the Committee may cause a legend or legends to be inscribed on any such certificates to make appropriate reference to such restrictions. Further, if certificates representing Restricted Stock are
registered in the name of the Participant, the Company may retain physical possession of the certificates and may require that the Participant deliver a stock power to the Company, endorsed in blank, related to the Restricted Stock. 

(d) Consideration for Grants. Awards may be granted for such consideration, including services, as the Committee shall determine, but
shall not be granted for less than the minimum lawful consideration. 
 (e) Additional Agreements. Each Eligible Person to whom an
Award is granted under the Plan may be required to agree in writing, as a condition to the grant of such Award or otherwise, to subject an Award that is exercised or settled following such Eligible Person’s termination of employment or service
to a general release of claims and/or a noncompetition or other restricted covenant agreement in favor of the Company and the Affiliates, with the terms and conditions of such agreement(s) to be determined in good faith by the Committee. 

8. Subdivision or Consolidation; Recapitalization; Change in Control; Reorganization. 

(a) Existence of Plans and Awards. The existence of the Plan and the Awards granted hereunder shall not affect in any way the right or
power of the Company, the Board or the stockholders of the Company to make or authorize any adjustment, recapitalization, reorganization or other change in the Company’s capital structure or its business, any merger or consolidation of the
Company, any issue of debt or equity securities ahead of or affecting Stock or the rights thereof, the dissolution or liquidation of the Company or any sale, lease, exchange or other disposition of all or any part of its assets or business or any
other corporate act or proceeding. 
 (b) Additional Issuances. Except as expressly provided herein, the issuance by the Company of
shares of stock of any class, including upon conversion of shares or obligations of the Company convertible into such shares or other securities, and in any case whether or not for fair value, shall not affect, and no adjustment by reason thereof
shall be made with respect to, the number of shares of Stock subject to Awards theretofore granted or the purchase price per share of Stock, if applicable. 

 (c) Subdivision or Consolidation of Shares. The terms of an Award and the share
limitations under the Plan shall be subject to adjustment by the Committee from time to time, in accordance with the following provisions: 

(i) If at any time, or from time to time, the Company shall subdivide as a whole (by reclassification, by a Stock split, by the issuance of a
distribution on Stock payable in Stock, or otherwise) the number of shares of Stock then outstanding into a greater number of shares of Stock or in the event the Company distributes an extraordinary cash dividend, then, as appropriate
(A) the maximum number of shares of Stock available for delivery with respect to Awards and applicable limitations with respect to Awards provided in Section 4 and Section 5 (other than
cash limits) shall be increased proportionately, and the kind of shares or other securities available for the Plan shall be appropriately adjusted, (B) the number of shares of Stock (or other kind of shares or securities) that may be acquired
under any then-outstanding Award shall be increased proportionately, and (C) the price (including the Exercise Price or grant price) for each share of Stock (or other kind of shares or securities) subject to then-outstanding Awards shall be
reduced proportionately, without changing the aggregate purchase price or value as to which outstanding Awards remain exercisable or subject to restrictions; provided, however, that in the case of an extraordinary cash dividend that is
not an Adjustment Event, the adjustment to the number of shares of Stock and the Exercise Price or grant price, as applicable, with respect to an outstanding Option or SAR may be made in such other manner as the Committee may determine that is
permitted pursuant to applicable tax and other laws, rules and regulations. Notwithstanding the foregoing, Awards that already have a right to receive extraordinary cash dividends as a result of Dividend Equivalents or other dividend rights will not
be adjusted as a result of an extraordinary cash dividend. 
 (ii) If at any time, or from time to time, the Company shall consolidate as a
whole (by reclassification, by reverse Stock split, or otherwise) the number of shares of Stock then outstanding into a lesser number of shares of Stock, then, as appropriate (A) the maximum number of shares of Stock available for
delivery with respect to Awards and applicable limitations with respect to Awards provided in Section 4 and Section 5 (other than cash limits) shall be decreased proportionately, and the kind of
shares or other securities available for the Plan shall be appropriately adjusted, (B) the number of shares of Stock (or other kind of shares or securities) that may be acquired under any then-outstanding Award shall be decreased
proportionately, and (C) the price (including the Exercise Price or grant price) for each share of Stock (or other kind of shares or securities) subject to then-outstanding Awards shall be increased proportionately, without changing the
aggregate purchase price or value as to which outstanding Awards remain exercisable or subject to restrictions. 
 (d)
Recapitalization. In the event of any change in the capital structure or business of the Company or other corporate transaction or event that would be considered an “equity restructuring” within the meaning of ASC Topic 718 and, in
each case, that would result in an additional compensation expense to the Company pursuant to the provisions of ASC Topic 718, if adjustments to Awards with respect to such event were discretionary or otherwise not required (each such an event, an
“Adjustment Event”), then the Committee shall equitably adjust (i) the aggregate number or kind of shares that thereafter may be delivered under the Plan, (ii) the number or kind of shares or other property
(including cash) subject to an Award, (iii) the terms and conditions of Awards, including the purchase price or Exercise Price of Awards and 

 
performance goals, as applicable, and (iv) the applicable limitations with respect to Awards provided in Section 4 and Section 5 (other
than cash limits) to equitably reflect such Adjustment Event (“Equitable Adjustments”). In the event of any change in the capital structure or business of the Company or other corporate transaction or event that would not be
considered an Adjustment Event, and is not otherwise addressed in this Section 8, the Committee shall have complete discretion to make Equitable Adjustments (if any) in such manner as it deems appropriate with respect to
such other event. 
 (e) Change in Control and Other Events. In the event of a Change in Control or other changes in the Company or
the outstanding Stock by reason of a recapitalization, reorganization, merger, consolidation, combination, exchange or other relevant change occurring after the date of the grant of any Award, the Committee, acting in its sole discretion without the
consent or approval of any holder, may exercise any power enumerated in Section 3 (including the power to accelerate vesting, waive any forfeiture conditions or otherwise modify or adjust any other condition or limitation
regarding an Award) and may also effect one or more of the following alternatives, which may vary among individual holders and which may vary among Awards held by any individual holder: 

(i) accelerate the time of exercisability of an Award so that such Award may be exercised in full or in part for a limited period of time on
or before a date specified by the Committee, after which specified date all unexercised Awards and all rights of holders thereunder shall terminate; 

(ii) redeem in whole or in part outstanding Awards by requiring the mandatory surrender to the Company by selected holders of some or all of
the outstanding Awards held by such holders (irrespective of whether such Awards are then vested or exercisable) as of a date, specified by the Committee, in which event the Committee shall thereupon cancel such Awards and pay to each holder an
amount of cash or other consideration per Award (other than a Dividend Equivalent or Cash Award, which the Committee may separately require to be surrendered in exchange for cash or other consideration determined by the Committee in its discretion)
equal to the Change in Control Price, less the Exercise Price with respect to an Option and less the grant price with respect to an SAR, as applicable to such Awards; provided, however, that to the extent the Exercise Price of an
Option or the grant price of an SAR exceeds the Change in Control Price, such Award may be cancelled for no consideration; 
 (iii) cancel
Awards that remain subject to a restricted period as of the date of a Change in Control or other such event without payment of any consideration to the Participant for such Awards; or 

(iv) make such adjustments to Awards then outstanding as the Committee deems appropriate to reflect such Change in Control or other such
event (including the substitution, assumption, or continuation of Awards by the successor company or a parent or subsidiary thereof); 
 provided,
however, that so long as the event is not an Adjustment Event, the Committee may determine in its sole discretion that no adjustment is necessary to Awards then outstanding. If an Adjustment Event occurs, this
Section 8(e) shall only apply to the extent it is not in conflict with Section 8(d). 

 9. General Provisions. 

(a) Tax Withholding. The Company and any Affiliate are authorized to withhold from any Award granted, or any payment relating to an
Award, including from a distribution of Stock, taxes due or potentially payable in connection with any transaction involving an Award, and to take such other action as the Committee may deem advisable to enable the Company, the Affiliates and
Participants to satisfy the payment of withholding taxes and other tax obligations relating to any Award in such amounts as may be determined by the Committee. The Committee shall determine, in its sole discretion, the form of payment acceptable for
such tax withholding obligations, including the delivery of cash or cash equivalents, Stock (including through delivery of previously owned shares, net settlement, a broker-assisted sale, or other cashless withholding or reduction of the amount of
shares otherwise issuable or delivered pursuant to the Award), other property, or any other legal consideration the Committee deems appropriate. Any determination made by the Committee to allow a Participant who is subject to Rule 16b-3 to pay taxes with shares of Stock through net settlement or previously owned shares shall be approved by either a committee made up of solely two or more Qualified Members or the full Board. If such tax
withholding amounts are satisfied through net settlement or previously owned shares, the maximum number of shares of Stock that may be so withheld or surrendered shall be the number of shares of Stock that have an aggregate Fair Market Value on the
date of withholding or surrender equal to the aggregate amount of such tax liabilities determined based on the greatest withholding rates for federal, state, foreign and/or local tax purposes, including payroll taxes, that may be utilized without
creating adverse accounting treatment for the Company with respect to such Award, as determined by the Committee. 
 (b) Limitation on
Rights Conferred under Plan. Neither the Plan nor any action taken hereunder shall be construed as (i) giving any Eligible Person or Participant the right to continue as an Eligible Person or Participant or in the employ or service of the
Company or any Affiliate, (ii) interfering in any way with the right of the Company or any Affiliate to terminate any Eligible Person’s or Participant’s employment or service relationship at any time, (iii) giving an Eligible
Person or Participant any claim to be granted any Award under the Plan or to be treated uniformly with other Participants and/or employees and/or other service providers, or (iv) conferring on a Participant any of the rights of a stockholder of
the Company unless and until the Participant is duly issued or transferred shares of Stock in accordance with the terms of an Award. 
 (c)
Governing Law; Submission to Jurisdiction. All questions arising with respect to the provisions of the Plan and Awards shall be determined by application of the laws of the State of Delaware, without giving effect to any conflict of law
provisions thereof, except to the extent Delaware law is preempted by federal law. The obligation of the Company to sell and deliver Stock hereunder is subject to applicable federal and state laws and to the approval of any governmental authority
required in connection with the authorization, issuance, sale, or delivery of such Stock. With respect to any claim or dispute related to or arising under the Plan, the Company and each Participant who accepts an Award hereby consent to the
exclusive jurisdiction, forum and venue of the state and federal courts located in New Castle County, Delaware. 

 (d) Severability and Reformation. If any provision of the Plan or any Award is or
becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction or as to any person or Award, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed
amended to conform to the applicable law or, if it cannot be construed or deemed amended without, in the determination of the Committee, materially altering the intent of the Plan or the Award, such provision shall be stricken as to such
jurisdiction, person or Award and the remainder of the Plan and any such Award shall remain in full force and effect. If any of the terms or provisions of the Plan or any Award Agreement conflict with the requirements of Rule 16b-3 (as those terms or provisions are applied to Eligible Persons who are subject to Section 16 of the Exchange Act) or Section 422 of the Code (with respect to ISOs), then those conflicting terms or
provisions shall be deemed inoperative to the extent they so conflict with the requirements of Rule 16b-3 (unless the Board or the Committee, as appropriate, has expressly determined that the Plan or such
Award should not comply with Rule 16b-3) or Section 422 of the Code, in each case, only to the extent Rule 16b-3 and such sections of the Code are applicable. With
respect to ISOs, if the Plan does not contain any provision required to be included herein under Section 422 of the Code, that provision shall be deemed to be incorporated herein with the same force and effect as if that provision had been set
out at length herein; provided, further, that, to the extent any Option that is intended to qualify as an ISO cannot so qualify, that Option (to that extent) shall be deemed a Nonstatutory Option for all purposes of the Plan. 

(e) Unfunded Status of Awards; No Trust or Fund Created. The Plan is intended to constitute an “unfunded” plan for certain
incentive awards. Neither the Plan nor any Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any Affiliate and a Participant or any other person. To the extent that
any person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any general unsecured creditor of the Company or such Affiliate. 

(f) Nonexclusivity of the Plan. Neither the adoption of the Plan by the Board nor its submission to the stockholders of the Company for
approval shall be construed as creating any limitations on the power of the Board or a committee thereof to adopt such other incentive arrangements as it may deem desirable. Nothing contained in the Plan shall be construed to prevent the Company or
any Affiliate from taking any corporate action which is deemed by the Company or such Affiliate to be appropriate or in its best interest, whether or not such action would have an adverse effect on the Plan or any Award made under the Plan. No
employee, beneficiary or other person shall have any claim against the Company or any Affiliate as a result of any such action. 
 (g)
Fractional Shares. No fractional shares of Stock shall be issued or delivered pursuant to the Plan or any Award, and the Committee shall determine in its sole discretion whether cash, other securities, or other property shall be paid or
transferred in lieu of any fractional shares of Stock or whether such fractional shares of Stock or any rights thereto shall be cancelled, terminated, or otherwise eliminated with or without consideration. 

 (h) Interpretation. Headings are given to the Sections and subsections of the Plan
solely as a convenience to facilitate reference. Such headings shall not be deemed in any way material or relevant to the construction or interpretation of the Plan or any provision thereof. Words in the masculine gender shall include the feminine
gender, and, where appropriate, the plural shall include the singular and the singular shall include the plural. In the event of any conflict between the terms and conditions of an Award Agreement and the Plan, the provisions of the Plan shall
control. The use herein of the word “including” following any general statement, term or matter shall not be construed to limit such statement, term or matter to the specific items or matters set forth immediately following such word or to
similar items or matters, whether or not non-limiting language (such as “without limitation”, “but not limited to”, or words of similar import) is used with reference thereto, but rather
shall be deemed to refer to all other items or matters that could reasonably fall within the broadest possible scope of such general statement, term or matter. References herein to any agreement, instrument or other document means such agreement,
instrument or other document as amended, supplemented and modified from time to time to the extent permitted by the provisions thereof and not prohibited by the Plan. 

(i) Facility of Payment. Any amounts payable hereunder to any individual under legal disability or who, in the judgment of the
Committee, is unable to manage properly his financial affairs, may be paid to the legal representative of such individual, or may be applied for the benefit of such individual in any manner that the Committee may select, and the Company shall be
relieved of any further liability for payment of such amounts. 
 (j) Conditions to Delivery of Stock. Nothing herein or in any Award
Agreement shall require the Company to issue any shares with respect to any Award if that issuance would, in the opinion of counsel for the Company, constitute a violation of the Securities Act, any other applicable statute or regulation, or the
rules of any applicable securities exchange or securities association, as then in effect. In addition, each Participant who receives an Award under the Plan shall not sell or otherwise dispose of Stock that is acquired upon grant, exercise or
vesting of an Award in any manner that would constitute a violation of any applicable federal or state securities laws, the Plan or the rules, regulations or other requirements of the SEC or any stock exchange upon which the Stock is then listed. At
the time of any exercise of an Option or SAR, or at the time of any grant of any other Award, the Company may, as a condition precedent to the exercise of such Option or SAR or settlement of any other Award, require from the Participant (or in the
event of his or her death, his or her legal representatives, heirs, legatees, or distributees) such written representations, if any, concerning the holder’s intentions with regard to the retention or disposition of the shares of Stock being
acquired pursuant to the Award and such written covenants and agreements, if any, as to the manner of disposal of such shares as, in the opinion of counsel to the Company, may be necessary to ensure that any disposition by that holder (or in the
event of the holder’s death, his or her legal representatives, heirs, legatees, or distributees) will not involve a violation of the Securities Act, any other applicable state or federal statute or regulation, or any rule of any applicable
securities exchange or securities association, as then in effect. Stock or other securities shall not be delivered pursuant to any Award until payment in full of any amount required to be paid pursuant to the Plan or the applicable Award Agreement
(including any Exercise Price, grant price, or tax withholding) is received by the Company. 
 (k) Section 409A of the
Code. It is the general intention, but not the obligation, of the Committee to design Awards to comply with or to be exempt from the Nonqualified Deferred Compensation Rules, and Awards will be operated and construed accordingly. Neither this
Section 9(k) nor any other provision of the Plan is or contains a representation to any Participant regarding the tax consequences of the grant, vesting, exercise, settlement, or sale of

 
any Award (or the Stock underlying such Award) granted hereunder, and should not be interpreted as such. In no event shall the Company be liable for all or any portion of any taxes, penalties,
interest or other expenses that may be incurred by the Participant on account of non-compliance with the Nonqualified Deferred Compensation Rules. Notwithstanding any provision in the Plan or an Award
Agreement to the contrary, in the event that a “specified employee” (as defined under the Nonqualified Deferred Compensation Rules) becomes entitled to a payment under an Award that would be subject to additional taxes and interest under
the Nonqualified Deferred Compensation Rules if the Participant’s receipt of such payment or benefits is not delayed until the earlier of (i) the date of the Participant’s death, or (ii) the date that is six months after the
Participant’s “separation from service,” as defined under the Nonqualified Deferred Compensation Rules (such date, the “Section 409A Payment Date”), then such payment or benefit
shall not be provided to the Participant until the Section 409A Payment Date. Any amounts subject to the preceding sentence that would otherwise be payable prior to the Section 409A Payment Date will be aggregated and paid in a lump sum
without interest on the Section 409A Payment Date. The applicable provisions of the Nonqualified Deferred Compensation Rules are hereby incorporated by reference and shall control over any Plan or Award Agreement provision in conflict
therewith. 
 (l) Clawback. The Plan and all Awards granted hereunder are subject to any written clawback policies that the Company,
with the approval of the Board or an authorized committee thereof, may adopt either prior to or following the Effective Date, including any policy adopted to conform to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and rules
promulgated thereunder by the SEC and that the Company determines should apply to Awards. Any such policy may subject a Participant’s Awards and amounts paid or realized with respect to Awards to reduction, cancelation, forfeiture or recoupment
if certain specified events or wrongful conduct occur, including an accounting restatement due to the Company’s material noncompliance with financial reporting regulations or other events or wrongful conduct specified in any such clawback
policy. 
 (m) Status under ERISA. The Plan shall not constitute an “employee benefit plan” for purposes of
Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended. 
 (n) Plan Effective Date and Term. The Plan
was adopted by the Board to be effective on the Effective Date. No Awards may be granted under the Plan on and after the tenth anniversary of the Effective Date, which
is                , 2032. However, any Award granted prior to such termination (or any earlier termination pursuant to Section 10), and the
authority of the Board or Committee to amend, alter, adjust, suspend, discontinue, or terminate any such Award or to waive any conditions or rights under such Award in accordance with the terms of the Plan, shall extend beyond such termination until
the final disposition of such Award. 
 10. Amendments to the Plan and Awards. The Committee may amend, alter, suspend,
discontinue or terminate any Award or Award Agreement, the Plan or the Committee’s authority to grant Awards without the consent of stockholders or Participants, except that any amendment or alteration to the Plan, including any increase in any
share limitation, shall be subject to the approval of the Company’s stockholders not later than the annual meeting next following such Committee action if such stockholder approval is required by any federal or state law or regulation or the
rules of any stock exchange or automated quotation system on which the Stock 

 
may then be listed or quoted, and the Committee may otherwise, in its discretion, determine to submit other changes to the Plan to stockholders for approval; provided, that, without the
consent of an affected Participant, no such Committee action may materially and adversely affect the rights of such Participant under any previously granted and outstanding Award. For purposes of clarity, any adjustments made to Awards pursuant to
Section 8 will be deemed not to materially and adversely affect the rights of any Participant under any previously granted and outstanding Award and therefore may be made without the consent of affected Participants.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]